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Liposomes have received increased attention in recent years. Nevertheless, liposomes, 
due to their various forms and applications, require further investigation. These 
structures can deliver both hydrophilic and hydrophobic drugs. The preparation of 
liposomes results in different properties for these systems. In addition, there are many 
factors and difficulties that affect the development of liposome drug delivery structures. 
The purpose of this book is to concentrate on recent developments in liposomes. The 
articles collected in this book are contributions by invited researchers with long-
standing experience in different research areas. We hope that the material presented 
here is understandable to a broad audience, not only scientists but also people with a 
general background in many different biological sciences. This volume offers up-to-date, 
expert reviews of the fast-moving field of liposomes and is divided in two major sections: 
1. Introduction; 2. Liposomes general properties
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is divided in two major sections encompassing four chapters. 
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In Chapter 2, lipid hydration and bilayer properties are described by Dr. Disalvo.
General perception of liposomes and their formation, manufacturing, and applica-
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Liposomes are vesicular arrangements composed of one or more phospholipid 
bilayers surrounding an aqueous core. Liposomes were discovered almost six 
decades ago. Due to its versatility, liposomes are now analyzed for their applicability 
both in laboratory techniques and in medical studies. Its interest lies in its ability 
to traverse cell membranes and to transport certain types of molecules to defined 
places in the human body.
Liposomes can carry both hydrophilic and hydrophobic molecules. The prepara-
tion of the liposomes results in different properties for these systems. There are 
several factors involved in the preparation of liposomes that can modify their 
structures. Due to its biological compatibility, nonimmunogenicity, greater solu-
bility of chemotherapeutic agents, and its ability to encapsulate a wide variety of 
drugs, the supply of drugs using liposomes has meant a great advance. The purpose 
of this book is to focus on recent developments in liposomes. The chapters selected 
in this book are contributions from invited researchers with long experience in 
different areas of research. This book offers expert and updated reviews of the field 
of liposomes.
2. Brief history of liposomes
Liposomes were discovered in 1961 by Alec Bangham, a British scientist who 
studied blood coagulation. Bangham and RW Horne were testing the new electron 
microscope of the Agricultural Research Council Institute of Animal Physiology, 
Babraham, Cambridge, England, when they observed for the first time applying the 
negative staining technique for the study of the structures of the lipid phase that 
the dispersions of lecithin contained spherulites composed of concentric sheets [1]. 
These images served as the first evidence that the cell membrane was a two-layered 
lipid structure. The width of the lipid layer was estimated at 44 Å. Preparations of 
phosphatidylcholine-cholesterol of equal molar ratios were described as basically 
the same as phosphatidylcholine alone.
A year later, in a Cambridge pub, Weissmann in a discussion with Bangham 
called these structures “liposomes” in honor of the lysosome, a simple organelle 
whose latency linked to the structure could be interrupted with detergents and 
streptolysins. [2], and that his laboratory had been studying: liposomes can be easily 
distinguished from micelles and hexagonal lipid phases by transmission electron 
microscopy by negative staining [3].
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3. My participation in studies with liposomes
Forty-four years ago, as an international scholar of the NIH in the Department 
of Biochemistry of the Health Center of the University of Connecticut, I carried out 
studies related to the mechanism of stearoyl-CoA desaturase [4]. That is where I 
first prepared liposomes by sonication of egg lecithin or dimyristoyl lecithin.
Since then I have used liposomes in multiple studies in order to analyze: the 
exchange of palmitic acid from cytosolic proteins to microsomes, mitochondria, and 
lipid vesicles [4]; the oleic acid transfer from microsomes to egg lecithin liposomes 
[5]; the interaction of albumin and fatty-acid-binding protein with membranes: oleic 
acid dissociation [6]; the removal of fatty acids but not phospholipids from micro-
somes liposomes and sonicated vesicles by fatty-acid-binding protein [7]; Fe2+- and 
Fe3+-initiated peroxidation of sonicated and nonsonicated liposomes made of retinal 
lipids in different aqueous media [8]; lipid peroxidation of membrane phospholipids 
in the vertebrate retina [9]; the antioxidant properties of melatonin and structural 
analogues on Fe(2+)-initiated peroxidation of sonicated liposomes made of retinal 
lipids [10]; the antioxidant behavior of melatonin and structural analogues during 
lipid peroxidation [11]; and the use of soybean phosphatidylcholine liposomes as 
model membranes to study lipid peroxidation photoinduced by pterin [12].
4. General remarks, conclusions, and perspectives
It has been fascinating to follow the field of liposomes research during almost 
five decades. From my experience, it is impossible to predict which aspects in 
liposomes research will dominate in the future.
Acknowledgements
The author is grateful to his mentors: Rodolfo Brenner and Phillip Strittmatter, 
all his Ph.D. students, and postdocs.
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Responsive Properties in Lipid 
Interphase of Biomimetic Systems
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Abstract
The lack of details in the hydration properties of lipid bilayers hinders the design 
of biomimetic systems that, as liposomes and vesicles, may be used for biotechno-
logical and medical purposes. In this chapter, studies indicate water as a membrane 
dynamic component determining the affinity and response of lipid membranes to 
amino acids, peptides and others stimuli. Based on thermodynamic analysis in lipid 
monolayers and its comparison with swelling shrinkage processes in liposomes and 
vesicles, it is concluded that: (1) the interphase of a lipid bilayer in a bidimensional 
solution of hydrated polar groups imbibed in labile water can be exchanged with 
the media by osmosis and or expansion-compression. (2) Excess water beyond the 
hydration shell (confined water) has solvent properties for additives in the bulk 
water phase and confers free energy that is in excess for binding of amino acids and 
peptides. (3) Dissolution in the water membrane phase changes the water activity 
(aw) and affects the surface pressure. (4) Defects may be formed by the compres-
sion of bilayers in which carbonyl groups organized water differently. These studies 
indicate that a deeper understanding of the role of lipid bilayers in cellular biology 
and support the development of future lipid-based biotechnology that should 
necessarily include the role of water as a membrane dynamic component.
Keywords: lipid bilayers, hydration, osmotic stress, responsive membranes, 
curvature, defects
1. Introduction: cell membranes and lipid membranes
Cell membranes are complex systems composed by lipids and proteins [1, 2]. They 
have structural and functional properties that are essential for life. The lipid bilayer 
is the backbone of cell membranes and is mostly composed by amphiphilic molecules 
such as phospholipids, cholesterol and glycolipids among others [3–7] (Figure 1).
A qualitative step in describing the membrane properties in terms of the lipid 
composition was the isolation and purification of lipids and its stabilization in water 
(Figure 1-Part B). After Bangham’s discovery in the 1960s [8, 9], lipids were found 
to form closed particles (liposomes) that are able to trap in controlled conditions 
such as ions, macromolecules and polar molecules of different nature in the inner 
aqueous space (Figure 2). With this information, it was thought reliable the pos-
sibility to modulate such trapping properties by changing membrane composition 
and to orient filled liposomes to specific organ targets. The changes were in the 
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Figure 1. 
(A) Electronic microscopic of cells; (B) cell membrane backbone is the lipid bilayer (a) which is formed by 
amphiphilic compounds such as lipids (single phospholipid) dispersed in water (b) facing the polar head group 
to water and segregating the acyl chains.
Figure 2. 
Organized water around the acyl chains is displaced promoting aggregation by an increase in entropy of the 
system (upper part). Lipids self-aggregate in water due to the hydrophobic interaction of the nonpolar chains 
forming closed particles such as liposomes (lower part).
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direction to modulate the surface properties, the excluded aqueous volume, the 
water permeability and the mechano-elastic properties of the particles.
In addition, different methodologies have been designed, afterwards, in order 
to obtain suspension of homogeneous size distribution of different magnitudes 
[10–12]. With this wide range of possibilities, it was immediate to infer that lipo-
somes and its different versions of covered or uncovered unilamellar vesicles would 
be the ideal tools to trap, vehiculate specific compounds to drive them to specific 
targets and deliver drugs to organs and tissues, specifically for human beings 
pathologies (Figure 3).
However, there are a number of difficulties for the direct use of these prepara-
tions that are mostly derived by limited knowledge of the physicochemical proper-
ties of the lipid bilayers. These include the presence of water as a major component 
in the membrane matrix; the thermodynamic properties derived from it in relation 
to the response from physicochemical stimuli and the interphase properties.
The purpose of this chapter is to analyze these points in order to propose new 
strategies for designing biomimetic lipid particles more efficiently.
2. Lipid hydration and bilayer stabilization
When dry phosphatidylcholines (PCs) of chain length above 12 hydrocarbon 
atoms are dispersed in water above their transition temperature as described in 
Figure 2, they form lamellar onion-like structures in which bilayers are separated 
by aqueous spaces that are available to trap the compounds of interest to vehiculize 
and deliver (Figure 4).
Figure 3. 
Liposomes are one of the most attractive biomimetic systems because its preparation is done with lipids 
extracted from cells. In addition, other biomimetic nanoparticles can include lipids in its matrix.
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After Bangham, Luzzati and others [13–15] determined the thickness of lipid 
bilayers by SAXS. Different thermal profiles were obtained according to the lipid 
features and head group structure was found [16–18]. Lipids stabilize differently 
according to its geometry. Phosphatidylcholines, that have similar areas in the head 
group region and the acyl chain, form bilayers by stacking molecules in cylindrical 
shape. In contrast, phosphatidylethanolamine (PE) forms hexagonal phases due to 
the conical shape of molecules [19, 20].
The process of lipid hydration that derives the formation of liposomes consists 
of different stages as described in Figure 5.
The hydration step consists of the increase in area and decrease in thickness up to 
around 20% c.a. 22–24 water molecules per lipid. After this stage, area and thickness 
remain constant and the swelling of liposomes starts by the increase of water in the 
interlamellar space. This description of lipid swelling illustrates about several struc-
tural and physicochemical properties of the bilayers. The first observation is that there 
is a defined number of water molecules per lipid that determines the area per lipid and 
the bilayer thickness. This number is around 7–8 below the phase transition tempera-
ture and 22–24 above as derived by DSC [17, 18, 21, 22]. Thus, water is a component of 
the structure of the lipid bilayer, determining its thermodynamic stability.
Figure 5. 
Hydration of lipids and swelling of liposomes.
Figure 4. 
(A) Electronic microscopic traditional image of multilamellar liposomes; (B) the diffraction pattern illustrates 
the separation between bilayers; (C) water solution trapped in between bilayers is schematically represented.
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At least four features deserve discussion. At equilibrium in fully hydrated state, 
the membrane thickness is composed by the excluded volume of the lipid molecules 
and the excluded volume of the water organized by them (the hydration number 
denoted above). Thus, the barrier properties do not only merge with the head group 
and the acyl chain region per se but also of the packing and arrangement of water 
molecules in the hydration shell of the phospholipids. This means that for any 
solute, to overcome the bilayers, that is, releasing the trapped solute or incorporat-
ing some of them must permeate or alter the hydration shell. This can, in principle, 
be done by some of these mechanisms: insertion in the water network removing or 
replacing water molecules in the hydration shell or changing the area per lipid by 
expansion or compression.
The second feature of lipid bilayers is derived from the first one. The interbilayer 
space consists of water not bound to the membrane, that is, it can be displaced by 
changing the osmotic gradient between the inner spaces and the outer media of the 
liposome. Water can permeate the lipid bilayer with certain facility depending on 
the phase state of the lipids, the presence of double bonds or ramifications in the 
acyl chains [23, 24]. In contrast, membrane is completely or partially impermeable 
to some solutes, such as sugars, ions, depending on its size and molecular structure. 
The differences in permeation rates between water and any of these solutes means 
that at least in the beginning of the process, a gradient of water chemical potential 
can be built with a difference in solute concentrations between the two sides of the 
bilayer. Let us consider the interbilayer space described in Figure 5. If solute is more 
concentrated between the bilayers, water will be driven to enter due to a difference in 
osmotic pressure and them the spacing (and hence the trapped volume) will be larger. 
An opposite effect can be caused, if the solute is concentrated in the outer media of 
the liposomes. In this case, liposomes shrink and the interbilayer space decreases.
The third feature is represented by an area per lipid for a membrane thickness of 
60 Å, when lipids hydrate with 22–24 water molecules per lipid. Thus, any change 
in the number of these water molecules will affect thickness and area with concomi-
tant effect on permeability.
Finally, the fourth feature is defined by the limit of the volume decrease. 
This is given by the steric repulsion of the groups in the surface of the bilayer, in 
which water plays a significant role. Water associated with the lipids is oriented 
at the bilayer surface constituting an electrical potential that hinder bilayers 
approach. This repulsive force is named as dipole potential or hydration forces 
[24–27] (Figure 6).
It is immediate to derive that the presence of these forces hinders the adhesion 
or fusion of membranes with different kinds of surfaces (inorganic and organic 
materials, other membranes, proteins, tissues, etc.). On the other way round, those 
processes will be feasible if water of hydration is totally or partially removed. This 
point is essential to understand the role of water in terms of membrane response to 
biologically relevant effectors.
Entering details of the dynamic properties of membranes in relation to water, 
we may again inspect Figure 5. The equilibrium point corresponding to an area per 
molecule of 75 Å and 20 water molecules per lipid could be modified by the inclu-
sion or exclusion of water molecules. So, the question is which perturbations can 
trigger changes in hydration that can be dominated in order to promote controlled 
changes in permeation. In this direction, let us focus on the mechanical and chemi-
cal forces at constant temperature. By mechanical forces, we refer to processes that 
led the membrane to expand or contract and by chemical forces, the competition 
with water by membrane sites of compounds may form hydrogen bonds. To analyze 
these points, previous considerations about water as a component of membranes 
must be done.
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in the number of these water molecules will affect thickness and area with concomi-
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changes in permeation. In this direction, let us focus on the mechanical and chemi-
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led the membrane to expand or contract and by chemical forces, the competition 
with water by membrane sites of compounds may form hydrogen bonds. To analyze 
these points, previous considerations about water as a component of membranes 
must be done.
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3. The bilayer structure and the water ratio
The understanding of the structural role of water in lipid membranes received 
considerable attention after Luzzatti et al. and efforts were addressed to give a 
defined location to water and to determine the appropriated values for area per lipid 
molecule [22, 27, 28]. Today, it is generally accepted that PCs admit up to a limit of 
around 22–24 water molecules per lipid above the phase transition temperature to 
stabilize in a bilayer with an area per lipid of 64 Å2 and a thickness of around 40 A 
[29, 30]. In the first stages of the hydration process, the water molecules interact 
with the phosphate group and, at a second step, with the carbonyl groups [31–33]. 
The formation of hydrogen bonds between these groups and water molecules can be 
monitored by observing the frequency shift of their stretching frequencies [34, 35]. 
It is expected that upon hydrogen-bonding, these frequencies decrease as a conse-
quence of the elongation of the chemical bonds in the relative functional groups. 
Furthermore, the conformation of the acyl chains changes with the hydration [36].
At least three regions of differential hydration can be identified according to 
the rate of exchange between membrane phase and the aqueous environment: the 
phosphate group, the carbonyl groups and the hydrocarbon chains. Each of them 
has different level of water organization in regard to coordination water by H bond-
ing [30]. From them, CO and acyl chains seem to be important to evaluate the role 
of water in regulatory and functional response [37, 38].
Figure 7 shows the lipid bilayer denoting the water region (upper part figure) 
and the profile of water distribution along the lipid bilayer (lower part).
It is observed that water covers all the phosphate and choline regions and par-
tially the carbonyl groups. Moreover, it is also observed that water may penetrate 
beyond the carbonyl region, that is, the first methylene groups of the hydrocarbon 
chains. This denotes that different arrangements of water can be found along the 
membrane thickness each of one with a different energetic profile, that is, the ability 
Figure 6. 
(A) The limit of approach of lipid bilayers, (B) water organized at the interphase determining the repulsion 
forces, (C) dipole potential at the lipid interphase. This potential makes the bilayer interior positive and has 
important consequences in the binding and penetration of charged peptides and proteins.
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to react with polar or ionic solutes. This reactivity can be ascribed to the residual 
capacity the water molecules have to form H bonds depending on the surface groups 
with which its interacts.
In Figure 8, water populations are visualized using infrared spectroscopy. Water 
bands at different frequencies denote the presence of non bonded to tetracoordi-
nated waters [35, 39].
A closer analysis by molecular simulation allows to explain that the broad bands 
can be ascribed to subpopulations of water molecule in four of the five groups 
described (Figure 9) [30].
Hence, in a population of molecules with three hydrogen bonds, the following 
combinations can be possible: www, ppp, ccc, wwp, wwc, wpp, wcc, wcp, ppw, 
ppc, etc. This means that the water distribution and the energy of the surface are 
extremely heterogeneous and hence a great versatility in reaction can be expected, 
even more if we consider that these combinations have a mean life time. Hence, the 
sites can be modified by fluctuations and these can in turn affect the presence of 
solute from the media and the lateral interaction at different lateral pressure of the 
bilayer. In this regard, the presence of proteins can alter this picture.
For a better understanding of the influence of the lateral pressure on the mem-
brane properties, we first deal with thermodynamic aspects of lipid monolayer. We 
will connect these properties with bilayer in the last part of the next section.
Figure 7. 
The lipid bilayer considering the water interphases. In the lower diagram, it is observed that the water profile 
(blue line) penetrates up to the region of the carbonyl groups (red solid and dashed lines), being phosphates 
(orange line) and cholines (green line) groups completely covered by water.
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4. Stability and membrane response: a dynamic picture
The thermodynamic stabilization of the lipids in water to form bilayers as a 
consequence of the hydrophobic interaction between acyl chains has been discussed 
in several previous paper and will not be analyzed here [40–42].
Instead, the thermodynamic aspects of the bilayer as a reactive surface consider-
ing its mechanical properties will specifically be discussed. This approach is based 
Figure 9. 
Distributions of subpopulations of water forming none, one, two, three and four H bonds. Numbers correspond 
to water (w), carbonyl (C) and phosphate (P). Thus, 2 1 0 means two H-bonds with water, one with carbonyl, 
none with phosphates.
Figure 8. 
Water bands in the adjacencies of lipid membranes in the gel (red line) and in the liquid crystalline state (blue 
line). Dotted lines denote the populations of water with none, one, two, three and four H-bonds. Central band 
at approximately 3500 cm−1 (red solid line) corresponds to bulk water without lipids.
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on the proposals presented earlier by Damoradan et al., Cevc, Disalvo et al. [37, 38, 
43–45]. In terms of interfacial properties, it is important to consider lipid interphases 
results that may give complementary information to present a more rigorous picture 
in terms of thermodynamic response. This implies to focus on the interfacial proper-
ties of the lipid arrangements both in bilayers and monolayers in which water is a 
component of the structure. For this reason, some general properties of lipid mono-
layers will be discussed to relate them in response with lipid bilayers of liposomes and 
vesicles to have a general formalism that can explain the behavior of both systems.
The main property inherent to membrane stabilization as a bilayer or as a mono-
layer is the surface tension of water. In the formation of bilayers, the surface tension 
between the acyl chain and water as described in Figure 2 is the main force driven 
the hydrophobic interaction. The increase in entropy is expressed by the decrease in the 
surface tension, that is, of the surface free energy. Hence the process is spontaneous.
When lipids spread on the air-water surface (Figure 10), monolayers are formed 
spontaneously by the same reason: decrease of the surface tension with respect to 
that of pure water (γ0) [46]. This is generally expressed as the surface pressure (Π) 
which is given by:
  Π =  γ 0 − γ  (1)
Figure 10. 
The addition of lipids to the air water surface in a Langmuir though at constant area increases the surface 
pressure (Π) by decreasing the water surface tension (γο) until a limit value is reached. From this point, the 
area per lipid molecule can be calculated.
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Figure 12. 
The effect of a soluble protease on the surface pressure of pure DMPC (black full triangles) and DMPE (red 
empty triangles).
Once the monolayer is stabilized at different lateral pressures (i. e. different 
surface excess of lipids), the response to perturbations promoted by solutes in the 
aqueous subphase can be tested (Figure 11).
As observed in Figure 12, the exclusion pressure or cut off, that is, the surface pres-
sure at which no further effect on the monolayer is observed depends on the head 
group region for a given acyl chain length. DMPE (mean hydration ratio, 7 water 
molecules per lipid) shows a lower exclusion pressure (cut off), than DMPC (water 
ratio 22–24 water per lipid), although the slope of the curves remains constant. 
Thus, in the whole range of pressure, PE monolayers are less reactive than those of 
PC in the same conditions [47].
In addition, the magnitude of the surface pressure increase is also dependent 
on the hydrocarbon composition for similar head group regions. In Figure 13, it is 
Figure 11. 
(A) Kinetic of surface pressure changes after the injection of the effector to the subphase. The extent of the 
change reflects the affinity of the effector by the monolayer, (B) surface pressure increase versus initial pressure 
plot used for determining the exclusion pressure of the lipid monolayer.
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observed that the response at a given pressure increases with the unsaturation or 
ramification of the acyl chains and decreases with the presence of cholesterol [47, 48].
The surface pressures below the critical cut off (Πc) are those states of the 
membrane interphase with propensity to react when chased by an effector in the 
subphase. These states correspond to different water/lipid ratio and hence different 
surface tension of water in the lipid matrix. The decrease in surface pressure Πc − Π 
is related to the increase of water beyond the hydration water (confined water) which 
part of it is distributed along the hydrocarbon chains. This can be followed by fre-
quency changes in the methylene region by FTIR spectroscopy (Figure 14) [49, 50].
5. Bilayer barrier properties: permeation and controlled release
The studies in lipid monolayers allow to conclude that the response of the 
membrane to stimuli is due to the excess of surface tension due to the increase 
Figure 13. 
Effect on the magnitude of the surface pressure response to a soluble protease of (A) unsaturation of the acyl 
chains in phosphatidylcholines, (B) inclusion of cholesterol in phosphatidylcholine monolayers.
Figure 14. 
Dehydration produces a decrease in confined water between acyl chains.
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(A) Kinetic of surface pressure changes after the injection of the effector to the subphase. The extent of the 
change reflects the affinity of the effector by the monolayer, (B) surface pressure increase versus initial pressure 
plot used for determining the exclusion pressure of the lipid monolayer.
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observed that the response at a given pressure increases with the unsaturation or 
ramification of the acyl chains and decreases with the presence of cholesterol [47, 48].
The surface pressures below the critical cut off (Πc) are those states of the 
membrane interphase with propensity to react when chased by an effector in the 
subphase. These states correspond to different water/lipid ratio and hence different 
surface tension of water in the lipid matrix. The decrease in surface pressure Πc − Π 
is related to the increase of water beyond the hydration water (confined water) which 
part of it is distributed along the hydrocarbon chains. This can be followed by fre-
quency changes in the methylene region by FTIR spectroscopy (Figure 14) [49, 50].
5. Bilayer barrier properties: permeation and controlled release
The studies in lipid monolayers allow to conclude that the response of the 
membrane to stimuli is due to the excess of surface tension due to the increase 
Figure 13. 
Effect on the magnitude of the surface pressure response to a soluble protease of (A) unsaturation of the acyl 
chains in phosphatidylcholines, (B) inclusion of cholesterol in phosphatidylcholine monolayers.
Figure 14. 
Dehydration produces a decrease in confined water between acyl chains.
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of water beyond the hydration shell, mostly in the acyl chain region. This excess 
is produced in monolayers by increasing the area per lipid, that is, reducing the 
surface pressure. In terms of bilayers, the expansion can be achieved by submit-
ting liposomes to a hypotonic swelling. In this condition, membrane expands and 
liposomes become leaky of solute trapped in the liposome interior in isotonic 
conditions. Hence, the modulation of the mechanical properties of the bilayer by 
lipid composition, for instance, by including different cholesterol ratios, would 
allow to have a controlled release. The plots in Figure 13 help to understand this 
response. At a given surface pressure, the response decreases with the increase 
in cholesterol, which can be related to an increase in the membrane rigidity and 
lower water ratio [16, 51].
Thus, permeability (i.e. the ratio between trapped and released solute) 
depends on the extent of water in the acyl region and in the second shell of phos-
phate groups. An important derivation of these results is that the properties of 
permeability can no longer be described by a model that assumes that the mem-
brane is composed of three slabs: a low dielectric region (the hydrocarbon chains) 
and the two aqueous interphases, where the polar groups are located (Figure 7). 
This view predicts that solute permeating the membrane would be those that can 
partition in a non-polar media [52]. However, polar amino acids and hydrophilic 
compounds such as glycerol, erythritol and urea permeate easily the lipid bilayer. 
In addition, when swelling is taken place, ions and large molecules such as sucrose 
trapped in liposomes in isotonic conditions can permeate when they osmotically 
swell [53, 54].
Therefore, solute permeation involved in the release of trapped solutes is a more 
complex phenomenon than a simple partition process. In terms of water participa-
tion at the membrane interphase and in the acyl chain region, the mechanism would 
involve water reorganization and hence structural changes. To put this complexity 
into relevance, the interaction of polyarginines (Arg 9) with bilayers of lipids dif-
fering in hydration such as phosphatidylcholines and phosphatidylethanolamines 
will be discussed. In Figure 15, the adsorption isotherm of Arg 9 on liposomes com-
posed by PC and PE are shown. Both present typical curves of saturation, denoting 
a limited number of sites with the affinity to bind Arg 9 are present in each surface 
[55]. They can be described by Eq. (2):
   (2)
where θ is the degree of coverage of the liposome by Arg 9, K the dissociation 
constant and n is a stoichiometric coefficient of the binding. In the present case, 
θ has been calculated by the change in the surface potential at each Arg 9 con-
centration measured by electrophoretic mobility from plots as shown in part A of 
Figure 15.
The fitting of the curves of part B gives an affinity constant for DMPC at 18°C, 
K = 0.54 × 103 ± 44 M−1 and a value n = 1. For DMPE at 18°C, K = 2 × 103 ± 189 M−1 
and n = 0.74 ± 0.06. According to these results, the affinity of Arg 9 is higher in 
DMPC than in DMPE. In addition, the interaction of Arg 9 with DMPC is well 
described by a Langmuir isotherm, since n = 1. In contrast, the value of n is differ-
ent from 1 for Arg 9 in DMPE suggesting different mechanisms of interaction. 
The strong difference in affinity between PE and PC membrane can be explained 
recalling the monolayer results. The cut off described in Figure 12 is much lower in 
PE than in PC, that is, at pressure above 32 mN/m at which PE is not affected, PC 
monolayer is still reactive. This can be explained by the strong interaction between 
the polar head groups of the PE molecules that restrict the water excess and hence 
decreasing responsiveness.
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6. Topological effects of osmotic shrinkage. Defects in packing
As described above, liposomes and vesicles, as well as cells, respond to osmom-
eters [54]. That is, their volumes increase or decrease as a consequence of the 
entrance or exit of water driven by osmotic gradients. In the previous section, 
we show that in swelling conditions, bilayer expansion produces changes in its 
permeability, that is, osmosis does not only affect the liposome volume but also the 
membrane density. Now we will see that it also affects the surface properties.
In hypertonic media, liposomes shrink, that is, they expulse the free water in the 
internal volume. However, the volume decrease has a limit due to the repulsive forces 
put in evidence at short distance as described in Figure 6. The overcoming of this 
repulsive barrier derives in adhesion or fusion of the surfaces and implies water 
elimination from the interphase. The compression process due to osmotic shrinkage 
in bilayers can be compared with the decrease in area in monolayers. In this system, 
at high pressures (i.e. low areas), monolayer collapses and lipids are lost. In bilay-
ers, the compression has different consequences due to the impossibility to extrude 
lipids from the bilayer.
Bilayers are soft and dynamic material [56, 57], and as a result, they can bend and 
deform in response to different stimuli such as dehydration and molecules that may 
compete with water. So, compression induced by osmotic shrinkage may result in 
topological changes giving place to regions (domains) of high curvature (invaginations 
or vesiculations) [58–60]. Thus, bilayer deformation can allow transient defects, when 
exposed to osmotic gradients (Figure 16). These curvature domains have important 
consequences in the interfacial behavior in the absorption or penetration of peptides 
composed by different types of amino acids. Many simulation studies showed that 
defect formation can determine the free energies of many membrane processes [61, 62].
When DPPC LUVs were subjected to hypertonic stress, defects caused by dehy-
dration have more affinity for lytic compounds and amino acids such as phenyl-
alanine [63–66]. The presence of defects in the membrane packing determines the 
binding and stabilization of peptides containing Arg and Phe motifs [67–69]
The disruption of the water network around the phenyl group and the mem-
brane defect has been invoked to explain the negative free energy of the formation 
a PC-Phe (phosphocholine-phenylalanine) complex in the presence of water. An 
important observation was that a dipole potential decrease was produced in this 
interaction which was explained by the orientation of the carboxylate opposing to 
the CO of the lipids [66, 70].
Figure 15. 
Adsorption of Arg 9 on DMPC and DMPE liposomes (A) change in zeta potential (ζ) of DMPC  and 
DMPE  liposomes with addition of increasing concentrations of Arg 9. θ is calculated by ζ − ζ0/ζ∞ − ζ0, 
where ζ is the value at a given Arg 9 concentration, ζ0 corresponds to liposomes in the absence of Arg 9 and ζ∞ 
the value at saturation. (B) Degree of coverage as calculated from part A versus Arg 9 concentration.
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Figure 17. 
Orientation of CO groups at the bilayer interphase in relation to curvature.
As described in Figure 9, carbonyl groups are one of the hydration centers in 
which interfacial water is distributed. The formation of high curvature surfaces is 
related to changes in the CO arrangements [39] (Figure 17).
The curvature domains, in fact, increases the bilayer free energy surface by 
exposing hydrophobic region and carbonyl configuration as observed in part B of 
Figure 17. The stabilization of peptides or amino acid is the result of the decrease 
of free energy at expense of the bending modulus, that is, the energy cost of 
topological changes [67, 71, 72]. This last quantity is an important parameter that 
governs a membrane’s tendency for defect formation. Many kinds of defects may 
be formed, including vesicle budding and fusion, depending on the presence of 
non-bilayer lipid phases, cholesterol and interactions between lipid bilayers and 
other biomolecules [19, 73].
Figure 16. 
Defects induced by osmotic shrinkage enhance Phe insertion into lipid bilayers.
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7. Concluding remarks: design and modulation
The lipid matrix in cell membranes presents a variety of lipids. As shown in 
Figure 18, all of them present a diacyl glycerol structure with acyl chains differ-
ing in saturation and length, a phosphate group in position 3 linked to a proton, 
choline, ethanolamine, glycerol, serine or inositol residues. It is difficult to accept 
that within the economicity principle of biology, this wide variation does not play a 
role in functional properties of the membrane.
It must be noticed that all lipids may be aligned along a plane containing the 
glycerol backbone and the carbonyl groups. On one side of this plane, the hydrocarbon 
region can vary in terms of chain length, saturation and ramification. Each of these 
variations may give a complex matrix in which water cannot be excluded and consti-
tute a media of a wide range of dielectric properties. On the other, polar groups pro-
trude into the aqueous phase at different magnitudes. Importantly, also these groups 
are able in different extents to form hydrogen bonds between its lipid neighbors and 
with water. In conclusion, it is an oversimplification to reduce the bilayer structure in which 
lipids organize facing the polar groups to water and segregating the nonpolar chains.
The lack of details in these regions in relation to their emergent properties is a 
major limitation in the design of biomimetic systems that, as liposomes and vesicles, 
may be used for biotechnological and medical purposes. As a consequence, literature 
is saturated with works in which only “try and error” strategies are employed.
In this chapter, we have briefly discussed that:
• the interface is a bidimensional solution of hydrated polar groups.
• excess water beyond the hydration shell has solvent properties for additives 
in the bulk water phase and confers free energy that is excess for binding of 
amino acids and peptides.
• Dissolution in the water membrane phase changes the water activity (aw) and 
affects the surface pressure.
Figure 18. 
Protrusion of the groups esterified to the phosphate in the surface of the membrane promotes different water 
organization.
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These studies indicate a deeper understanding of the role of lipid bilayers in  
cellular biology and support the development of future lipid-based biotechnology  
that should necessarily include the role of water as a membrane dynamic component.
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Abstract
Liposomes are currently part of the most reputed carriers for various molecular 
species, from small and simple to large and complex molecules. Since their discovery, 
liposomes have been subject to extensive evolution, in terms of composition, manu-
facturing and applications, which led to several openings in both basic and applied life 
sciences. However, most of the advances in liposome research have been more devoted 
to launching new developments than improving the existing technology for potential 
implementation. For instance, the evolution of the conventional lipid hydration meth-
ods to novel microfluidic technologies has permitted upscale production, but with 
increase in manufacturing cost and persistent use of organic solvents. This chapter 
intends to present general concepts in liposome technology, highlighting some long-
standing bottlenecks that remain challenging to the preparation, characterization and 
applications of liposomal systems. This would enhance the understanding of the gaps 
in the field and, hence, provide directions for future research and developments.
Keywords: phospholipids, soybean lecithin, liposome composition, manufacturing 
methods, characterization techniques
1. Introduction
Liposomes are artificial lipid-based bilayered vesicles. They were firstly discov-
ered and described in 1965 by Bangham et al. [1] as swollen phospholipid systems, 
namely Banghasomes. A few years later, the structural description of liposomes was 
unveiled as small devices made of one or more closed phospholipid bilayers. Due to 
the diversity of particle sizes, from 20 nanometers to several micrometers, liposo-
mal vesicles are considered as either nanoparticles or microparticles endowed with 
the ability to encapsulate materials of various nature and polarity [2, 3].
Up until now, liposomes have shown huge promise as potential vehicles for 
biologically active compounds in cosmetic and pharmaceutical industries. These 
applications have been extended to food and farm industries, where unstable 
substances such as antioxidants, flavors and antimicrobials have been explored for 
liposomal encapsulation. Across all these areas of application, liposomes have been 
deemed to be the most successful delivery systems due to their multiple advantages. 
These include high biocompatibility and biodegradability, low toxicity and poor 
immunogenicity, improved drug solubility and controlled distribution, as well as 
31
Chapter 3
General Perception of Liposomes: 
Formation, Manufacturing and 
Applications
Christian Isalomboto Nkanga, Alain Murhimalika Bapolisi, 
Nnamdi Ikemefuna Okafor and Rui Werner Maçedo Krause
Abstract
Liposomes are currently part of the most reputed carriers for various molecular 
species, from small and simple to large and complex molecules. Since their discovery, 
liposomes have been subject to extensive evolution, in terms of composition, manu-
facturing and applications, which led to several openings in both basic and applied life 
sciences. However, most of the advances in liposome research have been more devoted 
to launching new developments than improving the existing technology for potential 
implementation. For instance, the evolution of the conventional lipid hydration meth-
ods to novel microfluidic technologies has permitted upscale production, but with 
increase in manufacturing cost and persistent use of organic solvents. This chapter 
intends to present general concepts in liposome technology, highlighting some long-
standing bottlenecks that remain challenging to the preparation, characterization and 
applications of liposomal systems. This would enhance the understanding of the gaps 
in the field and, hence, provide directions for future research and developments.
Keywords: phospholipids, soybean lecithin, liposome composition, manufacturing 
methods, characterization techniques
1. Introduction
Liposomes are artificial lipid-based bilayered vesicles. They were firstly discov-
ered and described in 1965 by Bangham et al. [1] as swollen phospholipid systems, 
namely Banghasomes. A few years later, the structural description of liposomes was 
unveiled as small devices made of one or more closed phospholipid bilayers. Due to 
the diversity of particle sizes, from 20 nanometers to several micrometers, liposo-
mal vesicles are considered as either nanoparticles or microparticles endowed with 
the ability to encapsulate materials of various nature and polarity [2, 3].
Up until now, liposomes have shown huge promise as potential vehicles for 
biologically active compounds in cosmetic and pharmaceutical industries. These 
applications have been extended to food and farm industries, where unstable 
substances such as antioxidants, flavors and antimicrobials have been explored for 
liposomal encapsulation. Across all these areas of application, liposomes have been 
deemed to be the most successful delivery systems due to their multiple advantages. 
These include high biocompatibility and biodegradability, low toxicity and poor 
immunogenicity, improved drug solubility and controlled distribution, as well as 
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the ability of performing surface modifications for targeted, extended and sus-
tained release. Currently, there are several liposomal formulations that are clinically 
established for the treatment of various diseases, such as cancer, fungal and viral 
infections; and many more have reached advanced phases of clinical trials [4, 5].
Although liposomes have shown some success in drug product development, the limi-
tations identified in liposomal technology have remained almost stagnant over decades. 
The most common disadvantages of liposomes arise partly from poor stability under 
shelf and in vivo conditions. This is mostly due to potential lipids oxidation and hydroly-
sis, leakage and loss of hydrophilic cargoes, as well as particles fission and fusion. To date, 
some of these problems can be circumvented by playing around formulation adjuvants, 
such as anti-oxidants, or post-preparation processing, such as freeze-drying [4, 6, 7].
While describing broadly the current perception of liposomes, regarding 
production, evaluation and applications; this chapter intends to highlight the 
longstanding bottlenecks that remained overlooked and challenging to product 
development and implementation. This would increase the understanding of the 
gaps in the field and provide future directions to new openings for improvements in 
liposome technology.
2. Liposomes formation and classification
2.1 Liposomes formation
The liposomal vesicles derive from hydration of phospholipids, which are 
amphiphilic molecules endowed with a hydrophilic head group and two hydropho-
bic acyl chains (Figure 1). In aqueous media, phospholipid molecules self-assemble 
Figure 2. 
Flowchart illustrating liposome formation and encapsulation of drug molecules.
Figure 1. 
Chemical structure of a representative phospholipid molecule (distearoyl phosphatidylcholine).
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into a bilayered structure. Within the bilayer, phospholipid polar groups line up to 
form a water-attracting surface while their lipophilic chains face each other to yield 
a water-free zone. On mechanical shaking or heating, phospholipid bilayers con-
tinuously enclose the dispersing aqueous medium and form a vesicular system. In 
this system, hydrophilic groups of phospholipids are oriented towards the inner and 
outer aqueous phase, while their hydrophobic tails are centered within the bilayer 
[2, 4]. This architecture underlines the ability of liposomes to readily encapsulate 
hydrophilic and hydrophobic materials inside the inner aqueous core and the lipid 
bilayers, respectively (as illustrated in Figure 2).
2.2 Liposomes classification
Depending on the particle size and number of bilayers forming the vesicles 
(lamellarity), liposomes can be categorized in the following classes [4, 8]:
• Small unilamellar vesicles (SUV), size range 20–100 nm;
• Large unilamellar vesicles (LUV), size >100 nm;
• Giant unilamellar vesicles (GULV), size >1000 nm;
• Oligolamellar vesicles (OLV), size range 100–1000 nm;
Vesicle 
designation
Main components Illustrative application
Emulsomes A mixture of fats and triglycerides 
stabilized by high proportion of 
lecithin
Emulsomes loaded with Amphotericin B for 
the treatment of visceral leishmaniasis [9]
Enzymosomes Complexes of lipids and enzymatic 
proteins
Encapsulation and delivery of superoxide 
dismutase for oxidative stress management [9]
Sphyngosomes Sphingolipids containing amide and 
ether bonds
Sphyngosomes loaded with vincristine 
(Marqibo®) for lymphoblastic leukemia 
therapy [4]
Transfersomes A mixture of single chain surfactant, 
phospholipids and ethanol (10%)
Transfersomes loaded with diclofenac for 
improved topical delivery/retention [10]
Ethosomes Phospholipids and ethanol 
(20–40%)
Mitoxantrone-loaded ethosomes for the 
treatment of melanoma [11]
Pharmacosomes Conjugate of drug and phospholipid Pharmacosomes loaded with diclofenac for 
enhanced the bioavailability and reduced 
toxicity [9]
Virosomes Viral glycoproteins Virosome containing HIV-1 gp41-subunit 
antigens for protection against vaginal 
simian-HIV [12]
Aquasomes Tin oxide, diamonds or brushite core 
covered with oligomeric film
PEG-lipid coated aquasomes containing 
interferon-α-2b for prolonged and enhanced 
cytotoxicity [13]
Bilosomes Bile salts and acids (deoxycholic 
acid)
Bilosomes loaded with diphtheria toxoid for 
systemic and mucosal immunization [14]
Niosomes Non-ionic surfactants (span and 
tween)
Niosomes based formulation for enhanced oral 
bioavailability of candesartan cilexetil [15]
Table 1. 
Presentation of liposome-type systems.
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the ability of performing surface modifications for targeted, extended and sus-
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this system, hydrophilic groups of phospholipids are oriented towards the inner and 
outer aqueous phase, while their hydrophobic tails are centered within the bilayer 
[2, 4]. This architecture underlines the ability of liposomes to readily encapsulate 
hydrophilic and hydrophobic materials inside the inner aqueous core and the lipid 
bilayers, respectively (as illustrated in Figure 2).
2.2 Liposomes classification
Depending on the particle size and number of bilayers forming the vesicles 
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Figure 3. 
Structural representation of ester glycerol-phospholipid molecules, with R1 and R2 representing the 
hydrocarbon chains of different fatty acids.
• Multilamellar large vesicles (MLV), with size >500 nm;
• Multivesicular vesicles, size from 1000 nm to several thousand nanometers.
Based on their composition, liposomes can be classified as conventional, long 
circulating, cationic, stimuli-responsive and immunoliposomes. The differences 
between these categories will be highlighted later when discussing composition and 
evolution of liposomes.
Furthermore, there are many other vesicular systems considered as part of the 
liposome-type vesicles. These include emulsomes, enzymosomes, sphyngosomes, 
transfersomes, ethosomes, pharmacosomes and virosomes, which are lipid-based 
liposomes analogous. The non-lipid-based liposomes analogous are aquasomes, 
bilosomes and niosomes [8, 9]. All the liposome-type systems are briefly presented 
in Table 1.
3. Liposomes composition and evolution
3.1 Liposomes composition
Liposomes are made of physiologically acceptable natural or synthetic phospho-
lipids found in the lipid bilayer membranes of human cells. The most frequently 
used phospholipids for liposomes preparation are phosphatidylcholines (PC), 
phosphatidylethanolamines (PE), phosphatidylserines (PS) and phosphatidylglyc-
erols (PG) [16]. The molecular structures of these biocompatible lipids are shown 
in Figure 3 and Table 2.
In liposomal technology, a considerable attention is given to the phase transition 
temperature (Tt) of these phospholipids. The Tt corresponds to the temperature 
above which phospholipids exist in liquid crystalline phase. In this fluid state, 
hydrophobic tails of phospholipids are randomly oriented but ready to form closely 
continuous bilayered vesicles (liposomes). Below the Tt, phospholipids exist in gel 
state, where the hydrophobic tails are completely expanded and well packed, thus 
not able to form liposomes [4, 17].
As most of the phospholipids used for liposomes formulation have Tt close to the 
physiological temperature (37°C), the addition of cholesterol has been adopted as a 
strategy to stabilize the liposomal vesicles in physiological media. This is especially 
for phospholipids that can undergo phase transition and leakage at room tempera-
ture, which can lead to premature release of the liposome cargo. In fact, due to its 
high hydrophobicity, cholesterol was found efficient in strengthening the packing 
of phospholipid bilayers, reducing therefore membrane permeability. Numerous 
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studies have reported the ability of cholesterol to impact liposomes properties and 
functionality, including encapsulation efficiency and release characteristics [18–
20]. The work by Kirby et al. [21] demonstrated that increasing cholesterol content 
can prevent leakage and improve in vivo stability of liposome. Later, Lopez-Pinto 
et al. [22] observed a direct correlation between cholesterol content and liposome 
sizes. These observations have established cholesterol content to be a key parameter 
in liposome formulation.
Like cholesterol, there are many other ingredients that can affect liposomes 
behavior and afford the desired encapsulation or delivery profiles. Additive agents 
such as oleic acid and N-[1(2,3-dioleoyloxy) propyl]-N,N,N-trimethylammonium 
chloride (DOTAP) are useful for the preparation of negatively and positively 
charged liposomes, respectively. These charged liposomes offer the advantage of 
great liposomal stability during the storage, as charged particles repel each and 
reduce aggregation tendencies. While the cell internalization of positively charged 
liposomes (cationic liposomes) is promoted by their electrostatic interaction with 
cell membranes (which are negatively charged), liposomes bearing negative charges 
are subjective to poor cell internalization due to the corresponding repulsive forces. 
Cationic liposomes are used in gene therapy due to their ability to successfully 
encapsulate nucleic acids by electrostatic forces [4, 23].
In addition, some special lipids such as cholesteryl hemisuccinate (CHEMS) and 
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), have been widely used to 
prepare liposomes with pH-dependent release features. CHEMS can exhibit pH-sensi-
tivity either alone or in the presence of other lipids. In ionized forms at basic or neutral 
pH, CHEMS stabilizes the lamellar form of DOPE in lipid-based vesicles. However, 
the protonated or molecular CHEMS formed at acidic pH promotes hexagonal phase 
of this lipid, which leads to the disruption of the vesicular systems and release of the 
encapsulated materials [24, 25]. Tocopherol hemisuccinate (THS) has also shown 
similar pH-responsiveness as CHEMS, due to their molecular similarity [26].
The composition of liposome appears to be a broad topic, but also very crucial 
for the desired product development. However, the nature and costs of the liposome 
components used over decades viz., particularly the synthetic or highly puri-
fied natural phospholipids, have been reported to be part of the factors affecting 
negatively the universal implementation and affordability of liposome technology 
[16, 27]. The review by Machado et al. [28] discussed the feasibility of using crude 
soybean and rice lecithin for liposomal encapsulation of food ingredients. The 
authors demonstrated these naturally occurring phospholipid mixtures could be 
useful for liposomes preparation regardless of the intended area of application. Our 
group has recently investigated liposomal encapsulation of isoniazid using crude 
soybean lecithin. The formulated liposomes exhibited much better encapsulation 
efficiency than purified soybean lecithin [29]. This study proposed crude soybean 
lecithin for liposomal encapsulation of drug molecules. However, the complexity 
of this lipid mixture might be a bottleneck for some biomedical applications, where 
molecular architecture of the lipid bilayer is explored to get insights into potential 
Phospholipids PC PE PS PG
Table 2. 
Description of –X moieties of different glycerol-phospholipids [16].
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20]. The work by Kirby et al. [21] demonstrated that increasing cholesterol content 
can prevent leakage and improve in vivo stability of liposome. Later, Lopez-Pinto 
et al. [22] observed a direct correlation between cholesterol content and liposome 
sizes. These observations have established cholesterol content to be a key parameter 
in liposome formulation.
Like cholesterol, there are many other ingredients that can affect liposomes 
behavior and afford the desired encapsulation or delivery profiles. Additive agents 
such as oleic acid and N-[1(2,3-dioleoyloxy) propyl]-N,N,N-trimethylammonium 
chloride (DOTAP) are useful for the preparation of negatively and positively 
charged liposomes, respectively. These charged liposomes offer the advantage of 
great liposomal stability during the storage, as charged particles repel each and 
reduce aggregation tendencies. While the cell internalization of positively charged 
liposomes (cationic liposomes) is promoted by their electrostatic interaction with 
cell membranes (which are negatively charged), liposomes bearing negative charges 
are subjective to poor cell internalization due to the corresponding repulsive forces. 
Cationic liposomes are used in gene therapy due to their ability to successfully 
encapsulate nucleic acids by electrostatic forces [4, 23].
In addition, some special lipids such as cholesteryl hemisuccinate (CHEMS) and 
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), have been widely used to 
prepare liposomes with pH-dependent release features. CHEMS can exhibit pH-sensi-
tivity either alone or in the presence of other lipids. In ionized forms at basic or neutral 
pH, CHEMS stabilizes the lamellar form of DOPE in lipid-based vesicles. However, 
the protonated or molecular CHEMS formed at acidic pH promotes hexagonal phase 
of this lipid, which leads to the disruption of the vesicular systems and release of the 
encapsulated materials [24, 25]. Tocopherol hemisuccinate (THS) has also shown 
similar pH-responsiveness as CHEMS, due to their molecular similarity [26].
The composition of liposome appears to be a broad topic, but also very crucial 
for the desired product development. However, the nature and costs of the liposome 
components used over decades viz., particularly the synthetic or highly puri-
fied natural phospholipids, have been reported to be part of the factors affecting 
negatively the universal implementation and affordability of liposome technology 
[16, 27]. The review by Machado et al. [28] discussed the feasibility of using crude 
soybean and rice lecithin for liposomal encapsulation of food ingredients. The 
authors demonstrated these naturally occurring phospholipid mixtures could be 
useful for liposomes preparation regardless of the intended area of application. Our 
group has recently investigated liposomal encapsulation of isoniazid using crude 
soybean lecithin. The formulated liposomes exhibited much better encapsulation 
efficiency than purified soybean lecithin [29]. This study proposed crude soybean 
lecithin for liposomal encapsulation of drug molecules. However, the complexity 
of this lipid mixture might be a bottleneck for some biomedical applications, where 
molecular architecture of the lipid bilayer is explored to get insights into potential 
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cell membrane permeability. The versatility of crude soybean lecithin liposomes 
is therefore in question, considering the wide range of areas that the liposomal 
systems usually cover.
3.2 Liposomes evolution
Based on the composition, liposomal systems can be considered to have evolved 
from conventional, long circulating, targeted and immune-liposomes to stimuli-
responsive liposomes. The liposomes composed purely of phospholipids with or 
without cholesterol (conventional liposomes) have shown some limitations due to 
their uptake by the cells of the mononuclear phagocytic system (MNPS), such as 
macrophages that ensure liposomes clearance through phagocytosis. This biological 
fate makes conventional liposomes appropriate vehicles for targeted drug delivery 
to infected MNPS cells, like the case of alveolar macrophages where Mycobacterium 
tuberculosis resides often. However, the uptake by the MNPS cells decreases lipo-
somes half-life and exposes to high risk of therapeutic failure when the site of 
interest is beyond the MNPS [2].
Extensive studies conducted in liposome technology led to identification of 
some astute strategies for addressing the issue of MNPS’ attack viz., liposome 
downsizing and surface modification. In this regard, it was observed that the physi-
ological clearance of larger liposomes (MLV) was much quicker than that of smaller 
liposomes (SUL), which describe long-circulating profiles with increased half-lives 
[30]. The stealth strategy arising from surface modification involved grafting or 
coating hydrophilic polymers such as polyethylene glycol (PEG) and chitosan, 
which prevents detection of liposomes by the MNPS cells. While stealth behavior 
allows liposomes to achieve much longer circulation time (hence the name “long 
circulating liposomes”), this strategy comes along with poor targeting efficiency 
due to wider distribution of liposomes in the body. From this limitation, further 
developments have led to introduction of targeted liposomes. These liposomes are 
characterized by surface decoration with glycoproteins, polysaccharides or specific 
receptors ligands to achieve narrowed distribution and accumulation at the site of 
interest [9, 31]. The observation that ligand-decorated liposomes could provide 
selective drug accumulation inspired further design of antibody-functionalized 
liposomes (immunoliposomes) as well as stimuli-responsive liposomal systems 
for controlled drug delivery [32]. Figure 4 shows the trend in the development of 
“intelligent” liposomes for site-specific delivery; from conventional liposomes, 
stealth liposome, targeted liposomes, immunoliposomes to stimuli-responsive 
liposomes.
Stimuli-responsive liposomes are smart liposomal systems that exhibit rapid 
release of the cargo upon changes in some physicochemical or biochemical stimuli, 
such as pH, temperature, redox potentials, enzymes concentrations, ultrasound, 
electric or magnetic fields [33, 34]. Among these stimuli, pH change is the most 
promising stimulus due to the existence of multiple pH gradients in the body [35]. 
In common practice, formulation of pH-sensitive liposomes involves incorporation 
of CHEMS and DOPE. Although CHEMS-DOPE-based liposomes have shown great 
promise for controlled delivery [24, 25, 36], the costly status of these lipids remains 
a deep concern for wider development and application of liposome products. To 
circumvent the use of such special lipids for pH-dependent delivery, our group has 
considered hydrazone derivatization of isoniazid (INH), as a small hydrophilic drug 
model, followed by encapsulation using crude soybean lecithin for cost-effective 
development [37]. Being poorly water soluble, the prepared conjugates were suc-
cessfully embedded within the lipid membranes and INH release experiments were 
conducted in different pH media. The INH-conjugate loaded crude soybean lecithin 
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liposomes have demonstrated attractive nanoparticulate and stimuli-responsive 
characteristics for potential low-cost site-specific liposomal delivery [38]. However, 
the amounts of INH-derivatives loaded were found to be almost 10-folds lesser than 
the loading achieved when native INH was encapsulated in crude soybean lecithin 
liposomes, which was in turn associated with some burst release [29]. This is prob-
ably due to the fact that INH derivatives are encapsulated in the lipid bilayer, which 
offers limited space for loading [39], while the native INH was trapped within the 
aqueous core of liposomes. These limitations underline the need for further devel-
opments in liposome technology to achieve controlled release from cost-effective 
liposomes, combining both use of cheap lipids and high drug loadings.
4. Liposomes preparation and characterization
4.1 Preparation methods
Liposomes can be prepared using a wide range of methods that involve combina-
tion of lipids with aqueous media, and somehow affect liposomes characteristics, 
such as size, lamellarity and encapsulation efficiency (EE). The recently reported 
methods can be categorized as conventional, which mostly involve approaches that 
are easy to use at laboratory scale, and novel methods that appear to be more useful 
for up-scale production but require some special equipment [4].
4.1.1 Conventional methods
The most commonly used methods for formulation of liposomes share the fol-
lowing fundamental stages: (i) lipids dissolution in organic solvents, (ii) drying of 
the resultant solution, (iii) hydration of dried lipid (using various aqueous media), 
(iv) isolation of the liposomal vesicles, and (v) quality control assays [6]. While 
sharing these basic stages, the conventional preparation methods gather different 
advantages and disadvantages that are comparatively presented in Table 3.  
The specific technological details of these methods are separately discussed in the 
following paragraphs.
Figure 4. 
Schematic representation of the trend in liposome improvements for site specific delivery. (A) Conventional liposomes, 
(B) stealth liposome, (C) targeted liposomes, (D) immunoliposomes and (E) stimuli-responsive liposomes [32].
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4.1.1.1 Film hydration
Also known Bangham method, film hydration represents the simplest and oldest 
method used in liposome technology. In this method, lipids are firstly dissolved in 
a suitable organic solvent, and dried down to yield a thin film at the bottom of the 
flask. The obtained lipid film is hydrated using an appropriate aqueous medium to 
produce liposomal dispersion. The structural organization of the formed vesicles 
can be affected by the hydration conditions. A gentle hydration of the lipid film 
forms giant unilamellar vesicles (GULV), whereas a hash hydration gives rise to 
multilamellar vesicles (MLV) with poor size homogeneity, which requires an addi-
tional downsizing step. The most commonly used sizing methods include probe and 
bath sonication that afford production of small unilamellar vesicles (SUV). Despite 
its higher effectiveness, probe sonication is often blamed for potential contamina-
tion (with titanium from the titanium-based nozzle used for mechanical agitation), 
and production of local heat that can affect lipids and drugs stability. Although the 
two sonication methods produce liposomes with identical characteristics, the use of 
bath sonication remains a better option due to easy control of operational param-
eters. Another technique used for liposome sizing includes consecutive extrusion 
of the liposomal formulation through polycarbonate filters of defined pore sizes. 
In this method, the number of extrusion cycles is the key parameter to control for 
effective homogenization [4, 6].
4.1.1.2 Reverse phase evaporation
Reverse phase evaporation is an alternative method to the film hydration that 
involves formation of water-in-oil emulsion between the aqueous phase (containing 
hydrophilic materials) and the organic phase (containing lipids and any hydropho-
bic materials). A brief sonication of this mixture is required for system homogeni-
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on size, poor encapsulation efficiencies of 




Simple design, suitable 
encapsulation efficiency
Not applicable to fragile cargoes, use of large 
quantity of organic solvent, time consuming, 
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product, control of particle size
Presence of organic solvent, detergent residue, 
time consuming, low entrapment efficiency, poor 
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Heating method Simple and fast process, 
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for sterilization, possible 
up-scale production
The need for high temperature
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that turns subsequently into liposomal suspension. The liposomes can be isolated 
from the dispersion using centrifugation, dialysis or sepharose 24 column [28].
4.1.1.3 Solvent injection
Solvent injection involves quick injection of the lipid solution (in ethanol or 
diethyl ether) into an aqueous medium. The experiment is performed either at room 
or at higher temperature (e.g., 60°C), depending on whether the organic solvent 
is water-miscible or not. The liposomes prepared by solvent injection process are 
mostly polydispersed and highly contaminated by organic solvents, especially 
ethanol due to formation of azeotrope mixture with water. As presented in Table 3, 
solvent injection suffers from several drawbacks including continuous exposure of 
the therapeutic agents to high temperature and organic solvent that might affect both 
the stability and safety of the liposomal products [28, 40].
4.1.1.4 Detergent removal
In the detergent removal method, phospholipids are dissolved in aqueous 
solution containing detergents at critical micelle concentrations (CMC). Upon 
detergent removal, the reaction medium frees individual phospholipid molecules 
that self-assemble into bilayered structures. Detergent removal is mostly achieved 
by means of a dialysis bag, polystyrene-based absorber beads or Sephadex columns 
(gel permeation chromatography). Dilution of the resultant mixture with some 
appropriate aqueous medium leads to restructuration of the formed micelles that 
evolve to liposomes [4, 6].
4.1.1.5 Heating method
Among all the conventional methods, the heating method is known to be the 
most attractive method for liposomes preparation due to its organic solvent free 
characteristics. In the heating method, lipids are hydrated for 1 hour, and heated for 
another hour above the transition temperature of the phospholipids in the presence 
of a hydrating agent (glycerin or propylene glycol 3%). When cholesterol is part 
of the formulation, the reaction medium is heated up to 100°C because of its high 
melting point. Being prepared under heating conditions, the resultant liposomes 
can be readily used without any further sterilization treatments, which minimizes 
both formulation complexity and timing. In addition, there is no need for further 
removal of the hydrating agents employed, since these represent physiologically 
acceptable ingredients that are well-established for pharmaceutical applica-
tions. Moreover, the observation that these hydrating agents can prevent particle 
coagulation and sedimentation makes them much more attractive as stabilizer 
and isotonizing additives. The hydroxyl groups of these hydrating agents provide 
a cryoprotective effect that makes the heating method an efficient method for the 
formulation of inhalable liposomes [41, 42].
4.1.2 Novel preparation methods
4.1.2.1 Microfluidic channel method
Microfluidic methods include all the novel techniques that make use of micro-
scopic channels (in the size range of 5–500 μm). In this method, lipids are dissolved 
in an appropriate organic solvent (ethanol or isopropanol) and the resultant 
solution is propelled perpendicularly or in the opposite direction to the aqueous 
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4.1.1.1 Film hydration
Also known Bangham method, film hydration represents the simplest and oldest 
method used in liposome technology. In this method, lipids are firstly dissolved in 
a suitable organic solvent, and dried down to yield a thin film at the bottom of the 
flask. The obtained lipid film is hydrated using an appropriate aqueous medium to 
produce liposomal dispersion. The structural organization of the formed vesicles 
can be affected by the hydration conditions. A gentle hydration of the lipid film 
forms giant unilamellar vesicles (GULV), whereas a hash hydration gives rise to 
multilamellar vesicles (MLV) with poor size homogeneity, which requires an addi-
tional downsizing step. The most commonly used sizing methods include probe and 
bath sonication that afford production of small unilamellar vesicles (SUV). Despite 
its higher effectiveness, probe sonication is often blamed for potential contamina-
tion (with titanium from the titanium-based nozzle used for mechanical agitation), 
and production of local heat that can affect lipids and drugs stability. Although the 
two sonication methods produce liposomes with identical characteristics, the use of 
bath sonication remains a better option due to easy control of operational param-
eters. Another technique used for liposome sizing includes consecutive extrusion 
of the liposomal formulation through polycarbonate filters of defined pore sizes. 
In this method, the number of extrusion cycles is the key parameter to control for 
effective homogenization [4, 6].
4.1.1.2 Reverse phase evaporation
Reverse phase evaporation is an alternative method to the film hydration that 
involves formation of water-in-oil emulsion between the aqueous phase (containing 
hydrophilic materials) and the organic phase (containing lipids and any hydropho-
bic materials). A brief sonication of this mixture is required for system homogeni-
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that turns subsequently into liposomal suspension. The liposomes can be isolated 
from the dispersion using centrifugation, dialysis or sepharose 24 column [28].
4.1.1.3 Solvent injection
Solvent injection involves quick injection of the lipid solution (in ethanol or 
diethyl ether) into an aqueous medium. The experiment is performed either at room 
or at higher temperature (e.g., 60°C), depending on whether the organic solvent 
is water-miscible or not. The liposomes prepared by solvent injection process are 
mostly polydispersed and highly contaminated by organic solvents, especially 
ethanol due to formation of azeotrope mixture with water. As presented in Table 3, 
solvent injection suffers from several drawbacks including continuous exposure of 
the therapeutic agents to high temperature and organic solvent that might affect both 
the stability and safety of the liposomal products [28, 40].
4.1.1.4 Detergent removal
In the detergent removal method, phospholipids are dissolved in aqueous 
solution containing detergents at critical micelle concentrations (CMC). Upon 
detergent removal, the reaction medium frees individual phospholipid molecules 
that self-assemble into bilayered structures. Detergent removal is mostly achieved 
by means of a dialysis bag, polystyrene-based absorber beads or Sephadex columns 
(gel permeation chromatography). Dilution of the resultant mixture with some 
appropriate aqueous medium leads to restructuration of the formed micelles that 
evolve to liposomes [4, 6].
4.1.1.5 Heating method
Among all the conventional methods, the heating method is known to be the 
most attractive method for liposomes preparation due to its organic solvent free 
characteristics. In the heating method, lipids are hydrated for 1 hour, and heated for 
another hour above the transition temperature of the phospholipids in the presence 
of a hydrating agent (glycerin or propylene glycol 3%). When cholesterol is part 
of the formulation, the reaction medium is heated up to 100°C because of its high 
melting point. Being prepared under heating conditions, the resultant liposomes 
can be readily used without any further sterilization treatments, which minimizes 
both formulation complexity and timing. In addition, there is no need for further 
removal of the hydrating agents employed, since these represent physiologically 
acceptable ingredients that are well-established for pharmaceutical applica-
tions. Moreover, the observation that these hydrating agents can prevent particle 
coagulation and sedimentation makes them much more attractive as stabilizer 
and isotonizing additives. The hydroxyl groups of these hydrating agents provide 
a cryoprotective effect that makes the heating method an efficient method for the 
formulation of inhalable liposomes [41, 42].
4.1.2 Novel preparation methods
4.1.2.1 Microfluidic channel method
Microfluidic methods include all the novel techniques that make use of micro-
scopic channels (in the size range of 5–500 μm). In this method, lipids are dissolved 
in an appropriate organic solvent (ethanol or isopropanol) and the resultant 
solution is propelled perpendicularly or in the opposite direction to the aqueous 
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medium within the micro-channels. The continuous axial mixing of the organic 
and aqueous solutions leads to liposomes formation because of local diffusion 
of phospholipids in aqueous phase, which encourages the self-assembly process. 
Among many others, the micro hydrodynamic focusing method represents the 
most commonly used microfluidic method for liposomes formulation. This method 
produces small and large unilamellar vesicles, 40–140 nm, with good size homo-
geneity (mono dispersed feature). The other microfluidic techniques include the 
microfluidic droplets and the pulsed jet flow microfluidic methods. The microflu-
idic droplets method involves dissolution of phospholipids in hexane for prepara-
tion of giant liposomes (4–20 μm). In the pulsed jet flow microfluidic method, the 
conventional film hydration method has been modified by drying the lipid solution 
in microtubes. The resultant lipid film is hydrated within the microtubes through a 
perfusion process that produces much larger vesicles, 200–534 μm, with remarkable 
encapsulation efficiency [4, 43]. As common advantages, the microfluidic methods 
offer the possibility for production of vesicles with desired size, due to the versatil-
ity and flexibility of the methods. The disadvantages of these methods include the 
imperative use of organic solvent and drastic agitation, as well as difficulty for large 
scale production [40].
4.1.2.2 Supercritical fluidic method
While being considered as equivalent to the conventional reverse phase evapora-
tion method, supercritical fluidic technique represents the most important novel 
liposome preparation methods that makes use of a supercritical fluid, such as 
carbon dioxide (CO2) maintained under supercritical conditions (supercritical 
temperature and pressure). In this state, CO2 is an excellent solvent for the lipids. 
The high-performance liquid chromatography (HPLC) pump provides a continu-
ous flow of the aqueous phase into a view cell that contains the supercritical lipid 
solution, allowing phase transition of the dissolved phospholipids. Upon sudden 
decrease in pressure, CO2 gets completely removed and phospholipids self-assemble 
into a bilayered vesicular system. The supercritical fluidic method affords large 
unilamellar vesicles (100–1200 nm) with 5-fold higher encapsulation efficiency 
than the equivalent conventional method. Apart from being organic solvent-free 
methods, the supercritical fluidic method offers many other advantages such as 
the use of CO2, as a cheap and environmentally harmless solvent, possibility for 
controlling particle size, in situ sterilization and large-scale production in industrial 
settings. However, the disadvantages of the supercritical fluidic technique, includ-
ing particularly its high cost, low yield and use of high pressures (200–350 bar) 
which require special infrastructures, restrict their universal applications for wider 
developments of liposomal technology [4, 40, 43].
4.1.3 Post-preparation treatments
4.1.3.1 Freeze-thawing
The freeze-thawing treatment involves freezing the liposomes dispersion in 
liquid nitrogen, and subsequently thawing it at the temperature above the phase 
transition temperature of the lipids used for formulation. Upon freeze-thawing, the 
liposomal vesicles are subjected to fusion since the lipid bilayers become fluid and 
highly permeable, allowing extensive diffusion of hydrophilic molecules, which 
leads to important cryoconcentration. These structural modifications encourage 
encapsulation of hydrophilic materials that are poorly loaded in liposomes when 
conventional methods are used. This underlines the reason why freeze-thawing 
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represents an important treatment in liposome technology. Amongst the key 
parameters to be considered for freeze-thawing optimization are the number and 
duration of freeze-thawing cycles. These can impact significantly not only the 
encapsulation efficiency but also structural characteristics, i.e., liposomes lamellar-
ity and polydispersity [44, 45].
4.1.3.2 Freeze-drying
Commonly known as lyophilization, freeze-drying is a post-preparation treat-
ment for liposomes that is applied in both laboratory and industrial settings to pre-
serve the characteristics of liposomal products. Freeze-drying involves freezing of 
the aqueous samples and subsequent removal of ice by sublimation. Freeze-drying 
represents a very useful treatment for shelf stability of liposomal suspensions, since 
water molecules can trigger some chemical reactions and lead to modification of 
the cargo or excipients in the formulation. Freeze-drying appears to be of great 
interest when the prepared formulation contains thermos-sensitive materials such 
as proteins, nucleic acids, etc., which might undergo fast degradation when sub-
jected to heat-drying. The use of freeze-drying has gained considerable attention 
in liposome technology due to improved storage stability of liposomal products. 
Because of potential leakage of liposomes during freeze-drying, addition of hydro-
philic compounds, commonly called cryoprotective agents (such as carbohydrates), 
has been established to ensure good stability and quality of the final product. The 
cryoprotectants commonly used include mannitol, lactose, sucrose and trehalose. 
Among these, trehalose is the most reputed cryoprotecting agent since it preserves 
liposomes stability during and after freeze-drying treatment [6].
4.2 Characterization techniques
After production, liposome formulations are subjected to extensive charac-
terization, evaluating the physicochemical properties of liposomes that affect 
their shelf stability and biological performance. The most routinely investigated 
parameters in liposome characterization include vesicle size and size distribution 
(or polydispersity), surface charge (or Zeta potential), shape and morphology, 
lamellarity, encapsulation efficiency, phase behavior (or polymorphism) and 
in vitro release profile [4, 46]. Table 4 indicates the techniques used for evaluation 
of liposome characteristics. The most frequently used methods are briefly discussed 
in the following paragraphs.
4.2.1 Dynamic light scattering (DLS)
Also known as photon correlation spectroscopy or quasi-elastic light scattering, 
DLS represents the most commonly used method for determination of liposome 
size, size distribution (polydispersity) and Zeta potential (surface charge). DLS is 
done by an instrumental setting called Zetasizer Nano. The standard operational 
principle of DLS is based on continuous motion of dispersed particles due to their 
bombardment by solvent molecules (Brownian motion). This phenomenon causes 
remarkable scattering of the applied light. Since the extent of fluctuation in light 
intensity is associated with the diffusion rate of the suspended particles, which 
is related to particle diameter (smaller particles diffusing faster than the larger 
ones), the particle size is automatically deducted from the estimated amount of the 
scattered light. When addressing Zeta potential measurements, DLS allows surface 
charge determination by accessing changes in the scattered light intensity caused 
by particle motion due to the electric field applied. In other words, for surface 
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medium within the micro-channels. The continuous axial mixing of the organic 
and aqueous solutions leads to liposomes formation because of local diffusion 
of phospholipids in aqueous phase, which encourages the self-assembly process. 
Among many others, the micro hydrodynamic focusing method represents the 
most commonly used microfluidic method for liposomes formulation. This method 
produces small and large unilamellar vesicles, 40–140 nm, with good size homo-
geneity (mono dispersed feature). The other microfluidic techniques include the 
microfluidic droplets and the pulsed jet flow microfluidic methods. The microflu-
idic droplets method involves dissolution of phospholipids in hexane for prepara-
tion of giant liposomes (4–20 μm). In the pulsed jet flow microfluidic method, the 
conventional film hydration method has been modified by drying the lipid solution 
in microtubes. The resultant lipid film is hydrated within the microtubes through a 
perfusion process that produces much larger vesicles, 200–534 μm, with remarkable 
encapsulation efficiency [4, 43]. As common advantages, the microfluidic methods 
offer the possibility for production of vesicles with desired size, due to the versatil-
ity and flexibility of the methods. The disadvantages of these methods include the 
imperative use of organic solvent and drastic agitation, as well as difficulty for large 
scale production [40].
4.1.2.2 Supercritical fluidic method
While being considered as equivalent to the conventional reverse phase evapora-
tion method, supercritical fluidic technique represents the most important novel 
liposome preparation methods that makes use of a supercritical fluid, such as 
carbon dioxide (CO2) maintained under supercritical conditions (supercritical 
temperature and pressure). In this state, CO2 is an excellent solvent for the lipids. 
The high-performance liquid chromatography (HPLC) pump provides a continu-
ous flow of the aqueous phase into a view cell that contains the supercritical lipid 
solution, allowing phase transition of the dissolved phospholipids. Upon sudden 
decrease in pressure, CO2 gets completely removed and phospholipids self-assemble 
into a bilayered vesicular system. The supercritical fluidic method affords large 
unilamellar vesicles (100–1200 nm) with 5-fold higher encapsulation efficiency 
than the equivalent conventional method. Apart from being organic solvent-free 
methods, the supercritical fluidic method offers many other advantages such as 
the use of CO2, as a cheap and environmentally harmless solvent, possibility for 
controlling particle size, in situ sterilization and large-scale production in industrial 
settings. However, the disadvantages of the supercritical fluidic technique, includ-
ing particularly its high cost, low yield and use of high pressures (200–350 bar) 
which require special infrastructures, restrict their universal applications for wider 
developments of liposomal technology [4, 40, 43].
4.1.3 Post-preparation treatments
4.1.3.1 Freeze-thawing
The freeze-thawing treatment involves freezing the liposomes dispersion in 
liquid nitrogen, and subsequently thawing it at the temperature above the phase 
transition temperature of the lipids used for formulation. Upon freeze-thawing, the 
liposomal vesicles are subjected to fusion since the lipid bilayers become fluid and 
highly permeable, allowing extensive diffusion of hydrophilic molecules, which 
leads to important cryoconcentration. These structural modifications encourage 
encapsulation of hydrophilic materials that are poorly loaded in liposomes when 
conventional methods are used. This underlines the reason why freeze-thawing 
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represents an important treatment in liposome technology. Amongst the key 
parameters to be considered for freeze-thawing optimization are the number and 
duration of freeze-thawing cycles. These can impact significantly not only the 
encapsulation efficiency but also structural characteristics, i.e., liposomes lamellar-
ity and polydispersity [44, 45].
4.1.3.2 Freeze-drying
Commonly known as lyophilization, freeze-drying is a post-preparation treat-
ment for liposomes that is applied in both laboratory and industrial settings to pre-
serve the characteristics of liposomal products. Freeze-drying involves freezing of 
the aqueous samples and subsequent removal of ice by sublimation. Freeze-drying 
represents a very useful treatment for shelf stability of liposomal suspensions, since 
water molecules can trigger some chemical reactions and lead to modification of 
the cargo or excipients in the formulation. Freeze-drying appears to be of great 
interest when the prepared formulation contains thermos-sensitive materials such 
as proteins, nucleic acids, etc., which might undergo fast degradation when sub-
jected to heat-drying. The use of freeze-drying has gained considerable attention 
in liposome technology due to improved storage stability of liposomal products. 
Because of potential leakage of liposomes during freeze-drying, addition of hydro-
philic compounds, commonly called cryoprotective agents (such as carbohydrates), 
has been established to ensure good stability and quality of the final product. The 
cryoprotectants commonly used include mannitol, lactose, sucrose and trehalose. 
Among these, trehalose is the most reputed cryoprotecting agent since it preserves 
liposomes stability during and after freeze-drying treatment [6].
4.2 Characterization techniques
After production, liposome formulations are subjected to extensive charac-
terization, evaluating the physicochemical properties of liposomes that affect 
their shelf stability and biological performance. The most routinely investigated 
parameters in liposome characterization include vesicle size and size distribution 
(or polydispersity), surface charge (or Zeta potential), shape and morphology, 
lamellarity, encapsulation efficiency, phase behavior (or polymorphism) and 
in vitro release profile [4, 46]. Table 4 indicates the techniques used for evaluation 
of liposome characteristics. The most frequently used methods are briefly discussed 
in the following paragraphs.
4.2.1 Dynamic light scattering (DLS)
Also known as photon correlation spectroscopy or quasi-elastic light scattering, 
DLS represents the most commonly used method for determination of liposome 
size, size distribution (polydispersity) and Zeta potential (surface charge). DLS is 
done by an instrumental setting called Zetasizer Nano. The standard operational 
principle of DLS is based on continuous motion of dispersed particles due to their 
bombardment by solvent molecules (Brownian motion). This phenomenon causes 
remarkable scattering of the applied light. Since the extent of fluctuation in light 
intensity is associated with the diffusion rate of the suspended particles, which 
is related to particle diameter (smaller particles diffusing faster than the larger 
ones), the particle size is automatically deducted from the estimated amount of the 
scattered light. When addressing Zeta potential measurements, DLS allows surface 
charge determination by accessing changes in the scattered light intensity caused 
by particle motion due to the electric field applied. In other words, for surface 
Liposomes - Advances and Perspectives
42
charge (Zeta potential) evaluation, changes in the intensity of the scattered light are 
governed by the applied electric field (which causes extensive motion of charged 
particles), in contrast to size measurements where Brownian motion is the key fac-
tor [4, 47]. Apart from being a simple, fast and reliable method for routine analyses, 
DLS offers many other advantages including the fact that the measurement is taken 
from a native environment, and a wide size range can be evaluated (from a few 
nanometers to several micrometers). However, DLS shows some limitations such 
as the difficulty of differentiating individual particles from aggregates and high 
sensitivity to contaminants [48]. In addition, DLS is technically unable to provide 
true particle size, but rather hydrodynamic diameter due to particle solvation. 
Water layers on particle surface lead to false readings of particle diameters in aque-
ous media [49].
4.2.2 Transmission electron microscopy (TEM)
The microscopic observation provides direct visualization of the liposomal ves-
icles as individual particles, which allows effective analysis of shape and morphol-
ogy as well as a precise and reliable size reading. In this context, TEM techniques 
are commonly used in liposome technology for structural characterizations. In 
TEM experiments, the liquid sample is spotted onto a copper grid, and the solvent 
dried prior to the microscopic analysis. Under TEM instrument, liposomal vesicles 
mostly appear as black spherical particles on a white background. For a variant 
TEM technique like negative staining TEM, liposomes appear as bright spherical 
spots on a black background since the spotted sample is treated with uranyl acetate 
or phosphotungstic acid (as negative staining agent). Due to its effectiveness, TEM 
appears to be a powerful complementary technique to DLS for confirmation of 
the liposomal structure. Unlike DLS, TEM offers the advantage of differentiating 
individual vesicles from aggregates, allowing critical assessment of the liposome 
population. Nevertheless, TEM presents several limitations due to sample prepara-
tion. Apart from being time-consuming, sample pretreatments in TEM analyses 
may cause remarkable changes in liposomal shape or morphology: potential vesicle 
shrinkage, swelling or artifact formation [4, 50].
Parameters Analytical techniques
Particle size Dynamic light scattering (DLS), size exclusion chromatography (SEC), field-flow 
fractionation (FFF) and microscope technology: transmission electron microscopy 
(TEM), cryogenic-TEM (Cryo-TEM), and atomic force microscopy (AFM)





Microscopic techniques such as TEM, Cryo-TEM and AFM
Lamellarity Cryo-TEM and 31P-NMR
Phase behavior X-ray diffraction (XRD), differential scanning calorimetry (DSC) and 
thermogravimetric analysis (TGA)
Encapsulation efficiency Centrifugation, dialysis or column separation for liposomes isolation, followed 
by drug content determination
Drug release Dialysis or centrifugation, followed by drug quantification using analytical 
method, such as UV–Vis spectrophotometry, fluorescence spectrometry, 
enzyme- or protein-based assays, gel electrophoresis, HPLC, UPLC, LC-MS
Table 4. 
Analytical methods commonly used for liposomes characterization.
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To overcome these limitations, Cryo-TEM was developed as a strategy to mini-
mize liposome disruption by making use of a flash freezing treatment for direct 
particle visualization in solid-state (without solvent removal). Nowadays, Cryo-
TEM is the most reliable technique for visual determination of liposome structure 
including lamellarity. However, Cryo-TEM appears to be sometimes limited since 
it works perfectly only with very small particles. This has led to the development 
of atomic force microscopy (AFM) for direct particle analysis in native environ-
ments. Although AFM offers the advantage of higher particle resolution at three-
dimensional level, the use of this technique is mostly limited by the high cost of the 
instrument, which compromises its universal availability and accessibility [3, 4].
4.2.3 Differential scanning calorimetry (DSC) and X-ray diffraction (XRD)
DSC and XRD are complementary techniques that evaluate the thermal behavior 
and crystallinity, respectively, and provide valuable information for characteriza-
tion of loaded liposomes [46, 51, 52]. DSC evaluates the differences in heat flow 
(electric power) between a sample and a reference. In DSC experiments, the sample 
and the reference are subjected to a programmed heating, cooling or isothermal 
treatment in a controlled atmosphere (mostly saturated with nitrogen gas). The 
heating treatment is achieved either by the same heater (heat flux DSC) or by sepa-
rate heaters (power compensated DSC). The experiment is conducted in specialized 
metal pans made of aluminum, tin, zinc or indium. Throughout the experiment, 
frequent electric power adjustments occur upon material phase transition (melt-
ing or crystallization), ensuring thermal equilibrium between the sample and the 
reference. This phenomenon is described and expressed by the plot of heat capacity 
against temperature or time (heat flow curve). The heat flow curve provides the 
respective transition temperature and enthalpy, which allows to identify the nature 
of thermal events: endo- or exothermic [53–55]. DSC represents the most useful 
thermal analysis technique in the study of lipid-based materials [46, 52, 54–56].
Unlike DSC where sample recovery is not possible, XRD is a non-destructive ana-
lytical tool that allows structural investigations of crystalline materials. XRD makes 
use of X-rays that deeply penetrate solid materials and provide useful information at 
atomic structure level. Though relatively expensive, an XRD instrument is an envi-
ronmentally and user-friendly device that is easy to use. A wide range of materials 
such as powders, crystals and liquids can be quickly assessed by XRD. Its other advan-
tages include high resolution, reliability, relatively cheap maintenance, and easy data 
collection, processing and interpretation. The phase transitions and polymorphism 
determined by XRD represent valuable information in pharmaceutical development 
and production of both excipients and biologically active materials [57–59].
4.2.4 Lamellarity assays
The lamellarity of liposomes is part of their structural characteristics that can 
have an impact on the intended applications. The number of lipid bilayers can be 
evaluated using chemically labeled or radiolabelled agents that can be distributed 
in the bilayer membranes. However, this technique is limited since these reagents 
might be distributed only on the outer lipid membrane and lead to false readings. 
To date, Cryo-TEM is the most commonly used technique for the determination of 
lamellarity by visualization [4]. The nuclear magnetic resonance spectroscopy of 
the 31-phosphorus (31P-NMR) is also being currently used to estimate the lamel-
larity of liposomes. This technique deals with the estimation of the ratio of phos-
pholipid amount in the outer layers to that of the inner layers [60]. The 31P-NMR 
spectrum with a broad peak indicates the presence of MLV while a narrow peak 
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charge (Zeta potential) evaluation, changes in the intensity of the scattered light are 
governed by the applied electric field (which causes extensive motion of charged 
particles), in contrast to size measurements where Brownian motion is the key fac-
tor [4, 47]. Apart from being a simple, fast and reliable method for routine analyses, 
DLS offers many other advantages including the fact that the measurement is taken 
from a native environment, and a wide size range can be evaluated (from a few 
nanometers to several micrometers). However, DLS shows some limitations such 
as the difficulty of differentiating individual particles from aggregates and high 
sensitivity to contaminants [48]. In addition, DLS is technically unable to provide 
true particle size, but rather hydrodynamic diameter due to particle solvation. 
Water layers on particle surface lead to false readings of particle diameters in aque-
ous media [49].
4.2.2 Transmission electron microscopy (TEM)
The microscopic observation provides direct visualization of the liposomal ves-
icles as individual particles, which allows effective analysis of shape and morphol-
ogy as well as a precise and reliable size reading. In this context, TEM techniques 
are commonly used in liposome technology for structural characterizations. In 
TEM experiments, the liquid sample is spotted onto a copper grid, and the solvent 
dried prior to the microscopic analysis. Under TEM instrument, liposomal vesicles 
mostly appear as black spherical particles on a white background. For a variant 
TEM technique like negative staining TEM, liposomes appear as bright spherical 
spots on a black background since the spotted sample is treated with uranyl acetate 
or phosphotungstic acid (as negative staining agent). Due to its effectiveness, TEM 
appears to be a powerful complementary technique to DLS for confirmation of 
the liposomal structure. Unlike DLS, TEM offers the advantage of differentiating 
individual vesicles from aggregates, allowing critical assessment of the liposome 
population. Nevertheless, TEM presents several limitations due to sample prepara-
tion. Apart from being time-consuming, sample pretreatments in TEM analyses 
may cause remarkable changes in liposomal shape or morphology: potential vesicle 
shrinkage, swelling or artifact formation [4, 50].
Parameters Analytical techniques
Particle size Dynamic light scattering (DLS), size exclusion chromatography (SEC), field-flow 
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Table 4. 
Analytical methods commonly used for liposomes characterization.
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To overcome these limitations, Cryo-TEM was developed as a strategy to mini-
mize liposome disruption by making use of a flash freezing treatment for direct 
particle visualization in solid-state (without solvent removal). Nowadays, Cryo-
TEM is the most reliable technique for visual determination of liposome structure 
including lamellarity. However, Cryo-TEM appears to be sometimes limited since 
it works perfectly only with very small particles. This has led to the development 
of atomic force microscopy (AFM) for direct particle analysis in native environ-
ments. Although AFM offers the advantage of higher particle resolution at three-
dimensional level, the use of this technique is mostly limited by the high cost of the 
instrument, which compromises its universal availability and accessibility [3, 4].
4.2.3 Differential scanning calorimetry (DSC) and X-ray diffraction (XRD)
DSC and XRD are complementary techniques that evaluate the thermal behavior 
and crystallinity, respectively, and provide valuable information for characteriza-
tion of loaded liposomes [46, 51, 52]. DSC evaluates the differences in heat flow 
(electric power) between a sample and a reference. In DSC experiments, the sample 
and the reference are subjected to a programmed heating, cooling or isothermal 
treatment in a controlled atmosphere (mostly saturated with nitrogen gas). The 
heating treatment is achieved either by the same heater (heat flux DSC) or by sepa-
rate heaters (power compensated DSC). The experiment is conducted in specialized 
metal pans made of aluminum, tin, zinc or indium. Throughout the experiment, 
frequent electric power adjustments occur upon material phase transition (melt-
ing or crystallization), ensuring thermal equilibrium between the sample and the 
reference. This phenomenon is described and expressed by the plot of heat capacity 
against temperature or time (heat flow curve). The heat flow curve provides the 
respective transition temperature and enthalpy, which allows to identify the nature 
of thermal events: endo- or exothermic [53–55]. DSC represents the most useful 
thermal analysis technique in the study of lipid-based materials [46, 52, 54–56].
Unlike DSC where sample recovery is not possible, XRD is a non-destructive ana-
lytical tool that allows structural investigations of crystalline materials. XRD makes 
use of X-rays that deeply penetrate solid materials and provide useful information at 
atomic structure level. Though relatively expensive, an XRD instrument is an envi-
ronmentally and user-friendly device that is easy to use. A wide range of materials 
such as powders, crystals and liquids can be quickly assessed by XRD. Its other advan-
tages include high resolution, reliability, relatively cheap maintenance, and easy data 
collection, processing and interpretation. The phase transitions and polymorphism 
determined by XRD represent valuable information in pharmaceutical development 
and production of both excipients and biologically active materials [57–59].
4.2.4 Lamellarity assays
The lamellarity of liposomes is part of their structural characteristics that can 
have an impact on the intended applications. The number of lipid bilayers can be 
evaluated using chemically labeled or radiolabelled agents that can be distributed 
in the bilayer membranes. However, this technique is limited since these reagents 
might be distributed only on the outer lipid membrane and lead to false readings. 
To date, Cryo-TEM is the most commonly used technique for the determination of 
lamellarity by visualization [4]. The nuclear magnetic resonance spectroscopy of 
the 31-phosphorus (31P-NMR) is also being currently used to estimate the lamel-
larity of liposomes. This technique deals with the estimation of the ratio of phos-
pholipid amount in the outer layers to that of the inner layers [60]. The 31P-NMR 
spectrum with a broad peak indicates the presence of MLV while a narrow peak 
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corresponds to SUV. The addition of paramagnetic ions such as Mn2+, Co2+, and Pr3+ 
shifts the respective peaks to either downfield or upfield because of ionic interac-
tions with the phosphate backbone. By comparing the spectroscopic profile with 
and without the paramagnetic ion, the lamellarity of liposomes can be estimated. 
Some other techniques such as small-angle X-ray scattering (SAXS) and trapped 
volume determination can be used to estimate liposome lamellarity [4, 61].
4.2.5 In vitro release assays
The profile of release for the liposomal cargoes is commonly estimated in vitro 
using dialysis. This method implies trapping the liposomal dispersion into a dialysis 
bag of specific molecular weight cut off. The resultant tubing membrane is placed in 
a simulated physiological fluid (release medium) that is often a buffer maintained 
under well-defined conditions: specific temperature and speed of stirring/shaking. 
At predetermined time intervals, an aliquot is withdrawn from the release medium 
and an equal volume of the fresh buffer is replaced to maintain sink conditions. In 
the withdrawn sample aliquots, the released cargo is quantified using some rou-
tine analytical techniques such as UV-Vis spectrophotometry, HPLC, UPLC, etc., 
adapted to the molecular species under evaluation. The release profile is obtained 
by plotting the cumulative release percentage against the chosen time intervals [4]. 
Data from the in vitro release study are valuably considered as part of the rational 
development of formulations for controlled release, since they allow effective 
prediction of in vivo performance of the delivery systems [62].
5. Applications
Liposomes have evolved so far from mere experimental tools of research to 
industrially established products for clinical and veterinary use. They have shown the 
ability to improve the physicochemical features of the cargoes and ferry them to the 
sites of interest. The concepts of liposomal encapsulation have been applied in several 
fields of life science. Liposomes are frequently used for the delivery of drug, gene, 
vaccine and diagnostic products; but other applications encompass encapsulation of 
food and cosmetic ingredients as well as routine analysis of chemical substances  
[2, 3]. The following paragraphs briefly present the current applications of liposomes.
5.1 Application in drug delivery
The use of liposomes in drug delivery aims at modifying the pharmacokinetics 
of drugs to improve the therapeutic efficacy while minimizing potential toxicity 
[6]. Liposomes can alter the spatial and temporal distribution of the entrapped 
drug molecules in vivo, leading to controlled delivery at the site of interest and 
reduced off-target adverse effects [63]. The liposomal systems have been extensively 
investigated for the delivery of existing and emerging drugs at various research 
levels, from basic stages related to research and development to preclinical and 
clinical applications. Nowadays, liposomes represent the most clinically established 
drug vehicles for human diseases [3, 5]. The efforts invested in liposomal technol-
ogy have so far led to the development of several effective liposomal formulations 
that are currently used in clinics (Table 5).
Liposomal formulations have been used to address a wide range of pathological 
conditions through different administration routes, including dermal, transdermal, 
oral, pulmonary and parenteral routes. The clinical areas commonly explored in 
liposome research encompass skin disorders, cancers and infectious diseases [4]. 
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Amongst, cancer therapy appears to be in the forefront of liposome delivery, due to 
poor bioavailability and side effects of most of the anti-cancer drugs. However, sev-
eral infectious diseases, most specially where the pathogen is hosted by the MNPS 
(i.e., tuberculosis, leishmaniasis, fungal infections), have been reported to be good 
candidates for liposome application, taking advantage of the spontaneous lipo-
somes uptake by the cells of MNPS [2]. Apart from the nature and localization of 
the disease, the design and development of liposomes depend also on the intended 
administration route, since different anatomical and physiological characteristics 
can be encountered from one route to another [46].
Furthermore, the application of liposomes in drug delivery is highly dependent 
on their colloidal and physiochemical features, i.e., vesicle size, surface charge and 
system stability [64]. For instance, small liposomes (SUV) are good candidates for 
Parkinson’s and Alzheimer’s diseases, due to the need for crossing the brain blood 
barrier to achieve brain targeted delivery. Meanwhile, large liposomes are preferred 
for macrophage targeted delivery of antimicrobials, when pathogens are located 
inside the MNPS cells (e.g., tuberculosis, leishmaniasis), taking advantage of the 
passive liposome cell uptake [2, 4, 46]. This underlines the need for thorough explo-
ration of process and formulation parameters at early stages of products develop-
ment to produce liposomes with desired characteristics, making the technology for 
liposomes manufacturing key to future therapeutic research and development.
5.2 Application in gene delivery
Liposomes have been reported to achieve effective intracellular delivery of genes. 
These liposomes, also called lipoplexes, are generally made of cationic lipids, which 
allow for encapsulation of genetic materials via electrostatic interactions with the 
negatively charged phosphate backbones of nucleic acids. The positive charge on 
the surface of liposomes also influences their interactions with negatively charged 
cell membranes and promotes cell internalization [23, 65]. Cationic liposomes offer 
several advantages over viral gene vectors, including easy and safe production, 
Branded 
product
Drug name Therapeutic indications
Abelcet Amphotericin B Fungal infections
AmBisome Amphotericin B Fungal infections
Amphocil Amphotericin B Fungal infections
DaunoXome Daunorubicin Hematological malignancy
DepoCyt Cytarabine Lymphomatous meningitis
DepoDur Morphine sulfate Pain relief
Doxil Doxorubicin Kaposi’s sarcoma and solid tumors
Epaxal Inactivated hepatitis A virus Hepatitis A
Evacet Doxorubicin Ovarian cancer
Inflexal V Inactivated hemagglutinin of influenza virus 
strains A and B
Influenza
LipoDox Doxorubicin Kaposi’s sarcoma and solid tumors
Marqibo Vincristine sulfate Acute lymphoblastic leukemia
Visudyne Verteporfin Photodynamic therapy
Table 5. 
Clinically approved liposomal products [3, 4].
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Furthermore, the application of liposomes in drug delivery is highly dependent 
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Parkinson’s and Alzheimer’s diseases, due to the need for crossing the brain blood 
barrier to achieve brain targeted delivery. Meanwhile, large liposomes are preferred 
for macrophage targeted delivery of antimicrobials, when pathogens are located 
inside the MNPS cells (e.g., tuberculosis, leishmaniasis), taking advantage of the 
passive liposome cell uptake [2, 4, 46]. This underlines the need for thorough explo-
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ment to produce liposomes with desired characteristics, making the technology for 
liposomes manufacturing key to future therapeutic research and development.
5.2 Application in gene delivery
Liposomes have been reported to achieve effective intracellular delivery of genes. 
These liposomes, also called lipoplexes, are generally made of cationic lipids, which 
allow for encapsulation of genetic materials via electrostatic interactions with the 
negatively charged phosphate backbones of nucleic acids. The positive charge on 
the surface of liposomes also influences their interactions with negatively charged 
cell membranes and promotes cell internalization [23, 65]. Cationic liposomes offer 
several advantages over viral gene vectors, including easy and safe production, 
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cost effectiveness, possibility of monitoring toxicity, biodegradability, biocompat-
ibility and lack of dangerous immunogenicity. However, they are suffering from 
poor transfection efficiency due to their limited endosomal escaping ability, which 
exposes the genetic materials to enzymatic and acid degradation in lysosomes. This 
has been improved by incorporating fusogenic lipids, such as DOPE, in the liposomal 
formulation. These helper lipids facilitate endosomal escaping by membrane fusion 
with endosomes, leading to early cytoplasmic release of the gene. Though cationic 
liposomes have shown some dose-dependent toxicity, successful results have been 
obtained in cancer therapy when delivering genes encoding for tumor suppression 
proteins [66, 67]. He et al. have recently developed folate receptor alpha-targeted 
lipoplexes with therapeutic gene expression regulated by an hTERT promoter. These 
liposomes have shown some promise for the treatment of ovarian cancer [68].
5.3 Application in vaccine delivery
The use of specific lipids or molecules such as phosphatidylserine, DOTAP, 
fatty acids and monophosphoryl lipids can produce liposomes with attractive 
immune-stimulating activities. Liposomes carrying antigenic materials, either 
encapsulated in the aqueous core, grafted or coated on the surface; can stimulate 
immune responses on macrophage uptake. Following endolysosomal degradation, 
macrophages present the antigen to T-lymphocytes that initiate the production of 
cytokines and specific antibodies via activation of B-lymphocytes [4]. The immune 
response produced by liposomes can be influenced by their composition, lamel-
larity, size and surface charge [69]. Liposomes containing a glycolipid, trehalose 
6,6'-dibehenate, and a cationic lipid, dimethyldioctadecylammonium, in a 1:5 mass 
ratio have demonstrated efficient delivery of the TB vaccine Ag85B-ESAT-6. This 
vaccine has shown prolonged immune response without any toxic effects [70]. 
Although a liposomal vaccine (namely Stimuvax®) targeting the major histocom-
patibility class I complex for lung carcinoma was not successfully implemented, 
some other vaccines such as Epaxal®, Inflexal® V and Mosquirix® have been 
clinically established for the treatment of hepatitis A, influenza virus infections and 
malaria, respectively. These vaccines, classified as virosomes, are liposomes gener-
ally made of reconstituted viral envelop supplemented with phosphatidylcholine. 
They offer the advantage of undergoing membrane fusion either with the cells or 
the endosomes, and thus leading to efficient cytosolic delivery [2, 9].
5.4 Application in diagnosis
The use of liposomes for diagnostic purposes is one of current topics of great 
interest in biomedical applications. Liposomes with magnetic properties, also 
called magnetoliposomes, are made by entrapping superparamagnetic iron-based 
nanoparticles or iron oxides or gadolinium (III) chelates for magnetic resonance 
imaging. Functionalized liposomes labeled with radioisotopes can also be used as 
molecular probes in nuclear imaging. For instance, liposomes labeled with 64Cu, 18F, 
89Zr or 52Mn have been reported in positron emission tomography while 99mTC, 111In 
or 67Ga labeled liposomes were applied in single photon emission computed tomog-
raphy. Acoustic liposomes which are liposomes made of perfluoropropane gas can 
be used as contrast agents in ultrasound imaging technique. The encapsulation of 
quantum dots and fluorescent dyes into liposomes has also led to the development 
of attractive liposomal platforms for diagnosis. Additionally, liposomes have shown 
great potential for simultaneous accommodation of drugs and diagnostic agents 
such as radionuclides, magnetic or contrast substances. This can be achieved by 
encapsulation in the inner core, embedding in the lipid bilayer, chemically grafting 
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or coating onto the surface of liposomes. A successful targeted co-delivery of these 
materials has given to liposomes the status of theranostic systems, as they provide 
both the therapeutic effect and the diagnostic control [2, 71, 72].
5.5 Application in analytical fields
In analytical domains, liposome-based formulations can be usefully involved in 
immunoassays, biosensors analysis and liquid chromatography. Liposomes can be 
used to encapsulate, embed or conjugate the analytical entities with high loading 
capacity and huge surface area that can enhance the intensity of analytical signal. In 
a direct enzyme-linked immunosorbent assay (ELISA) like method, fluorophore-
conjugated liposomes carrying a substantial amount of secondary antibody quickly 
bind to the antigen that has been fixed on the primary antibody. The addition 
of a colorimetric substrate leads to color development and allows for analytical 
estimation of the antigenic analyte. The use of liposomes has been deemed to lower 
the limits of detection of analytes and increase the sensitivity of immunological 
analysis technique [73]. In chromatography, the conjugation of liposomes to the 
stationary phase for gel permeation chromatography is useful for separation of 
drugs and proteins and for exploring possible molecular interactions on phospho-
lipid membranes. Additionally, the cell-like appearance of liposomes makes them 
appropriate simulated cell models for studying and predicting the interactions 
between biologically active compounds and cell membranes [4].
5.6 Application in cosmetics
The use of liposomes in the field of cosmetics is based on the similarity between 
the lipid composition of the liposomal vesicle and that of the biological layers com-
posing the skin. Because phospholipids can be subject to hydration, topical liposomes 
happen to contribute to the reduction of skin dryness. While playing the role of 
attractive vehicles for relevant cosmetic agents, liposomes provide a great source of 
skin ingredients, such as essential unsaturated fatty acids like linolenic acid. This has 
shown great potential for maintaining the skin and hair in good physiological stand-
ing, preventing the rise of some common topical diseases. Furthermore, the use of 
skin care formulations made of empty or hydrating agents loaded liposomes helps to 
reduce the transdermal water loss, which is a major cause of skin dryness [74, 75].
5.7 Application in food industry
As versatile lipid-based systems, liposomes have shown some potential in the 
encapsulation of food ingredients. In this field, the use of liposomes aims to stabilize 
some nutraceutical or dietetic ingredients during the storage, to improve their organo-
leptic characters or to provide a controlled and targeted delivery of these substances 
in a specific tissue. The shelf life and efficacy of instable bioactive products such as 
vitamins, enzymes and anti-oxidative agents have been prolonged by their liposomal 
encapsulation. For example, proteinase and lipase loaded liposomes have been reported 
to improve the ripening of cheese notably in preventing proteolysis of casein [28, 76]. 
Yokota et al. [27] have successfully improved the taste and odor of casein hydrolysate 
in dietetic preparations by liposomal encapsulation. In addition to the encapsulation 
of dietetic compounds, liposomes have been recently used to encapsulate a cyanobac-
terium, namely Spirulina platensis, as a source of proteins [77]. Although the use of 
liposomes in food industry is still at the infant stages of development, advanced studies 
have been launched to investigate much more attractive applications, such as detection 
of food contaminants by means of stimuli-responsive liposomes for food safety [76].
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6. Conclusion
Liposomes appear to be reputed carriers for various chemical and macromolecu-
lar species. From way back their discovery, liposomes have been subject to extensive 
evolution, in terms of composition, manufacturing and usages, which led to several 
openings in both basic and applied life sciences. The general details presented 
herein attempted to reveal some of the existing gaps in liposomes technology and 
open new windows for further research. An important future breakthrough could 
be the discovery of cost-effective materials to formulate liposome vesicles with 
remarkable versatility viz., being suitable as vehicles for various molecules while 
holding a clear molecular architecture to act as cell models for in vitro bioassays. 
In addition, novel manufacturing methods for facile encapsulation of both hydro-
phobic and hydrophilic molecules with no need for organic solvents and special 
equipment or sophisticated infrastructures are highly desired. Furthermore, the 
critical issue of system instability for liposomes loaded with hydrophilic materials 
requires new strategies that will achieve acceptable loading while aiming at target-
ing cargo delivery at the site of interest. Finally, since liposomes have demonstrated 
some clinical success as drug vehicles, future efforts should be dedicated to ensur-
ing wider developments and implementation of therapeutic liposomes. This would 
enhance commercial availability and accessibility of liposome products across the 
globe, particularly in low- and middle-income countries.
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6. Conclusion
Liposomes appear to be reputed carriers for various chemical and macromolecu-
lar species. From way back their discovery, liposomes have been subject to extensive 
evolution, in terms of composition, manufacturing and usages, which led to several 
openings in both basic and applied life sciences. The general details presented 
herein attempted to reveal some of the existing gaps in liposomes technology and 
open new windows for further research. An important future breakthrough could 
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remarkable versatility viz., being suitable as vehicles for various molecules while 
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equipment or sophisticated infrastructures are highly desired. Furthermore, the 
critical issue of system instability for liposomes loaded with hydrophilic materials 
requires new strategies that will achieve acceptable loading while aiming at target-
ing cargo delivery at the site of interest. Finally, since liposomes have demonstrated 
some clinical success as drug vehicles, future efforts should be dedicated to ensur-
ing wider developments and implementation of therapeutic liposomes. This would 
enhance commercial availability and accessibility of liposome products across the 
globe, particularly in low- and middle-income countries.
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Simulations of Self-Assemblies of
Liposomes for Drug Delivery
Applications
Ketzasmin Armando Terrón-Mejía,
Inocencio Higuera-Ciapara, Evelin Martínez-Benavidez,
Javier Hernández and Roberto López-Rendón
Abstract
Liposomes are essential components in the development of functional materials
for drug delivery; this is mainly due to its ability to self-associate spontaneously and
form bilayer vesicles. In these potential applications, knowing the size of self-
assembled liposomes is essential for optimal performance; however, this process
still has many unanswered questions. Conventional experimental techniques to
study self-assemblies of liposome nanoparticles still have a great challenge. Com-
putational simulations emerge as an alternative to understand the role of thermo-
dynamic properties responsible for the self-assembly, particularly when they are
unreachable experimentally because of limited time and length resolutions. In this
chapter, we present the advantages and disadvantages of dissipative particle
dynamic method to explore the functioning of liposome self-assembly in the trans-
port of drugs.
Keywords: dissipative particle dynamics, liposomes self-assemblies, drug delivery,
capsaicin, chitosan polymers
1. Introduction
The scenario of the modern era of interdisciplinary research between the natural
sciences, including mathematics and theoretical physics, biophysics, chemistry,
colloid science, and biochemistry, among others, along with advances in computa-
tional sciences, makes possible the manipulation of matter on a molecular scale
through nanotechnology and bionanotechnology. This interdisciplinary research is
able to study nanosystems made of phospholipids can be self-assembled spontane-
ously. One of the most studied cases in recent years is the self-assembly of
liposomes.
The liposomes, vesicular systems based on lipids, in the last decades have
increased their potential of their applications in various scientific disciplines and
extensively been used as carriers for numerous molecules in cosmetic and pharma-
ceutical industries and medical and agricultural fields due to their high capacity and
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form bilayer vesicles. In these potential applications, knowing the size of self-
assembled liposomes is essential for optimal performance; however, this process
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1. Introduction
The scenario of the modern era of interdisciplinary research between the natural
sciences, including mathematics and theoretical physics, biophysics, chemistry,
colloid science, and biochemistry, among others, along with advances in computa-
tional sciences, makes possible the manipulation of matter on a molecular scale
through nanotechnology and bionanotechnology. This interdisciplinary research is
able to study nanosystems made of phospholipids can be self-assembled spontane-
ously. One of the most studied cases in recent years is the self-assembly of
liposomes.
The liposomes, vesicular systems based on lipids, in the last decades have
increased their potential of their applications in various scientific disciplines and
extensively been used as carriers for numerous molecules in cosmetic and pharma-
ceutical industries and medical and agricultural fields due to their high capacity and
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efficiency in drug delivery [1, 2]. For purposes in drug delivery systems, the
liposomes are suitable candidates, due to their multiple properties that make them
unique in these processes, such as biocompatibility, biodegradability, low toxicity,
ability to modify the pharmacokinetic profile of the drug loaded, etc. [3]. In this
way, liposomes have been successfully applied in the delivery of nucleic acid
systems [4], in the intestinal lymphatic delivery [5], for enhanced oral delivery
[6]. Allen and Cullis documented that these advances have led to numerous
clinical trials in such diverse areas as the delivery of anticancer, antifungal, and
antibiotic drugs; the delivery of gene medicines; and the delivery of anesthetics
and anti-inflammatory drugs [7]. Despite the innumerable applications and
advances of the drug delivery of liposomes, it presents enormous challenges still.
For instance, He et al. argued that by modulating the compositions of the lipid
bilayers and adding polymers or ligands, both the stability and permeability of
liposomes can be greatly improved for oral drug delivery [8]. In order to achieve
direct, effective, and selective delivery of the liposome itself, a deeper under-
standing of the mechanisms for interaction between the water/ligands/polymers
and the liposome is required [9]. It has been reported in different sources that the
mechanism of liposome formation is based on the unfavorable interactions occur-
ring between amphiphilic compounds and water molecules, where the polar head
groups of phospholipids are subjected to the aqueous phases of the inner, the
hydrophobic hydrocarbon tails are associated with the bilayer, and spherical core
shell structures are formed [10–12].
In addition to a large number of experiments that have been dedicated to the
study of the mechanism of liposome formation, computational studies have made
important contributions to the subject. These methodologies have been shown to be
very effective in knowing in a very specific way the role played by molecular
interactions in complex systems such as liposome self-assembly. Nowadays, it is
increasingly common for research protocols to include a computational analysis
prior to carrying out the experimental stage. Different techniques of computer
modeling can facilitate quantitative understanding of experimental observations
and secure fundamental interpretation of underlying phenomena [13]. For instance,
Thota and Jiang in an interesting review documented that with the use of simulation
methods, it is possible to elucidate the mechanisms of drug loading/release, which
are indispensable in the rational screening and designing new amphiphiles for high-
efficacy drug delivery [14].
Most of the computational studies for drug delivery use molecular dynamics
(MD) or Monte Carlo (MC) simulations to obtain structural and dynamic informa-
tion. In the case of MD, for example, the study of interactions is carried out
considering all atoms explicitly commonly. These interactions are evaluated by
analytical functions that form the so-called force fields. The level of precision of a
simulation with MD relies on the force field used. There are traditional force fields
such as CHARMM [15], AMBER [16], and OPLS [17] used to study the self-
assembly of complex systems such as liposomes. Due to the scheme of evaluation of
the interactions, which is through both the intra- and intermolecular forces, the MD
simulations are slow and computationally expensive when the number of atoms is
very large. This limitation makes it almost impossible to reach the time scales (of
the order of the microseconds and beyond) where the thermodynamic observables
have greater physical significance. For this reason, this technique turns out to be
little viable to study the systems planned in this work, although it is important to
point out that diverse groups use it with very successful results.
Modeling technique alternatives to MD have been developed with the aim of
overcoming the bottleneck when it is required to study systems composed of a
large number of atoms, as well as the issue of length time scales. One of those
56
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techniques is the dissipative particle dynamics (DPD). The main philosophy of the
DPD model is based on the so-called coarse-grained (CG) models. These models
allow to diminish considerably the number of atoms of a given system, grouping a
set of atoms, which can be a functional chemical group, into a single interaction site
called a bead, always trying to maintain the physics of the correct model. This size
reduction facilitates larger simulations of larger ones with larger systems, allowing a
more efficient exploration of phase space, but losing an atomistic description.
Despite the success of the DPD technique, very few groups have used it to obtain
detailed information on various aspects of self-assembly of liposomes. Goicochea
et al. used DPD for understanding the behavior of biopolymer brushes coating
drug-carrying liposomes in an aqueous environment [18]. Shen et al. with the help
of DPD simulations, they explored how the tethered PEG polymers will affect the
membrane wrapping process of PEGylated liposomes during endocytosis [19].
Yamamoto et al. used DPD simulations to study the spontaneous vesicle formation
of amphiphilic molecules in aqueous solution [20].
Another great advantage of the modeling methods such as DPD is to be able to
incorporate their algorithms into powerful supercomputing technologies such as
graphic processing units (GPUs). The combination of hardware and software with
DPD has allowed us to explore systems at time scales, which were unattainable a
few years ago. For instance, Wu et al. [21] presented a GPU-accelerated DPD with
parallel cell-list updating. On the other hand, Nguyen et al. [22] achieve a speedup
of up to 9.5x in the DPD simulations in the well-known LAMMPS code using
GPUs. Phillips et al. [23] also achieve important speedup of DPD using GPUs but
the HOOMD-blue code. Other important implementations of DPD in GPUs can be
found in Refs [24, 25]. Our group has been a pioneer in the use and application of
DPD methodologies using GPUs. We have developed a simulation code called
SIMES [26] (which is an acronym for simulation at mesoscopic time scale), a
production DPD software designed and implemented specifically to run on GPUs.
SIMES can simulate a broad spectrum of complex systems, including the self-
assemblies of liposomes. Readers interested in going deeper into this topic can
consult our contributions in the following references [27-30].
Recently, in a previous work of our group, we have studied the stability of
structures and the efficiency of the encapsulation of capsaicin, as well as the inter-
nal and superficial distribution of capsaicin and chitosan inside of a nanoliposome,
constituted by lecithin and coated with a shell of chitosan by DPD simulations [31].
We found that thermodynamic properties, such as the potential mean force, show
that the interaction between capsaicin and chitosan polymers is very weak com-
pared to that with lecithin. Besides, an association between capsaicin and chitosan
in presence of lecithin is not likely to occur. In this work, we managed to combine
the power of the DPD method with the power of the GPUs. The simulations
reported have been the longest so far by regarding the encapsulation of capsaicin by
liposomal nanoparticles.
Continuing with our research computational about self-assembly of molecular
components for the design of bionanomaterials focused on drug delivery applica-
tions, the objective of this chapter is to show the advantages offered by the
DPD technique to study the self-assembly mechanism of liposomes. As a specific
case study, we show the formation of liposomes loaded with capsaicin. Capsaicin,
a lipophilic drug, is the pungent vanilloid compound in spicy chili peppers. We
chose capsaicin because it is approved as a drug for the treatment of chronic pains
[32]. It is also an excellent candidate to be transported by natural polymers such as
chitosan [33]. In addition, it is widely recognized in the treatment of urological
disorders and the control of satiety and obesity [34], among other important
applications.
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efficiency in drug delivery [1, 2]. For purposes in drug delivery systems, the
liposomes are suitable candidates, due to their multiple properties that make them
unique in these processes, such as biocompatibility, biodegradability, low toxicity,
ability to modify the pharmacokinetic profile of the drug loaded, etc. [3]. In this
way, liposomes have been successfully applied in the delivery of nucleic acid
systems [4], in the intestinal lymphatic delivery [5], for enhanced oral delivery
[6]. Allen and Cullis documented that these advances have led to numerous
clinical trials in such diverse areas as the delivery of anticancer, antifungal, and
antibiotic drugs; the delivery of gene medicines; and the delivery of anesthetics
and anti-inflammatory drugs [7]. Despite the innumerable applications and
advances of the drug delivery of liposomes, it presents enormous challenges still.
For instance, He et al. argued that by modulating the compositions of the lipid
bilayers and adding polymers or ligands, both the stability and permeability of
liposomes can be greatly improved for oral drug delivery [8]. In order to achieve
direct, effective, and selective delivery of the liposome itself, a deeper under-
standing of the mechanisms for interaction between the water/ligands/polymers
and the liposome is required [9]. It has been reported in different sources that the
mechanism of liposome formation is based on the unfavorable interactions occur-
ring between amphiphilic compounds and water molecules, where the polar head
groups of phospholipids are subjected to the aqueous phases of the inner, the
hydrophobic hydrocarbon tails are associated with the bilayer, and spherical core
shell structures are formed [10–12].
In addition to a large number of experiments that have been dedicated to the
study of the mechanism of liposome formation, computational studies have made
important contributions to the subject. These methodologies have been shown to be
very effective in knowing in a very specific way the role played by molecular
interactions in complex systems such as liposome self-assembly. Nowadays, it is
increasingly common for research protocols to include a computational analysis
prior to carrying out the experimental stage. Different techniques of computer
modeling can facilitate quantitative understanding of experimental observations
and secure fundamental interpretation of underlying phenomena [13]. For instance,
Thota and Jiang in an interesting review documented that with the use of simulation
methods, it is possible to elucidate the mechanisms of drug loading/release, which
are indispensable in the rational screening and designing new amphiphiles for high-
efficacy drug delivery [14].
Most of the computational studies for drug delivery use molecular dynamics
(MD) or Monte Carlo (MC) simulations to obtain structural and dynamic informa-
tion. In the case of MD, for example, the study of interactions is carried out
considering all atoms explicitly commonly. These interactions are evaluated by
analytical functions that form the so-called force fields. The level of precision of a
simulation with MD relies on the force field used. There are traditional force fields
such as CHARMM [15], AMBER [16], and OPLS [17] used to study the self-
assembly of complex systems such as liposomes. Due to the scheme of evaluation of
the interactions, which is through both the intra- and intermolecular forces, the MD
simulations are slow and computationally expensive when the number of atoms is
very large. This limitation makes it almost impossible to reach the time scales (of
the order of the microseconds and beyond) where the thermodynamic observables
have greater physical significance. For this reason, this technique turns out to be
little viable to study the systems planned in this work, although it is important to
point out that diverse groups use it with very successful results.
Modeling technique alternatives to MD have been developed with the aim of
overcoming the bottleneck when it is required to study systems composed of a
large number of atoms, as well as the issue of length time scales. One of those
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techniques is the dissipative particle dynamics (DPD). The main philosophy of the
DPD model is based on the so-called coarse-grained (CG) models. These models
allow to diminish considerably the number of atoms of a given system, grouping a
set of atoms, which can be a functional chemical group, into a single interaction site
called a bead, always trying to maintain the physics of the correct model. This size
reduction facilitates larger simulations of larger ones with larger systems, allowing a
more efficient exploration of phase space, but losing an atomistic description.
Despite the success of the DPD technique, very few groups have used it to obtain
detailed information on various aspects of self-assembly of liposomes. Goicochea
et al. used DPD for understanding the behavior of biopolymer brushes coating
drug-carrying liposomes in an aqueous environment [18]. Shen et al. with the help
of DPD simulations, they explored how the tethered PEG polymers will affect the
membrane wrapping process of PEGylated liposomes during endocytosis [19].
Yamamoto et al. used DPD simulations to study the spontaneous vesicle formation
of amphiphilic molecules in aqueous solution [20].
Another great advantage of the modeling methods such as DPD is to be able to
incorporate their algorithms into powerful supercomputing technologies such as
graphic processing units (GPUs). The combination of hardware and software with
DPD has allowed us to explore systems at time scales, which were unattainable a
few years ago. For instance, Wu et al. [21] presented a GPU-accelerated DPD with
parallel cell-list updating. On the other hand, Nguyen et al. [22] achieve a speedup
of up to 9.5x in the DPD simulations in the well-known LAMMPS code using
GPUs. Phillips et al. [23] also achieve important speedup of DPD using GPUs but
the HOOMD-blue code. Other important implementations of DPD in GPUs can be
found in Refs [24, 25]. Our group has been a pioneer in the use and application of
DPD methodologies using GPUs. We have developed a simulation code called
SIMES [26] (which is an acronym for simulation at mesoscopic time scale), a
production DPD software designed and implemented specifically to run on GPUs.
SIMES can simulate a broad spectrum of complex systems, including the self-
assemblies of liposomes. Readers interested in going deeper into this topic can
consult our contributions in the following references [27-30].
Recently, in a previous work of our group, we have studied the stability of
structures and the efficiency of the encapsulation of capsaicin, as well as the inter-
nal and superficial distribution of capsaicin and chitosan inside of a nanoliposome,
constituted by lecithin and coated with a shell of chitosan by DPD simulations [31].
We found that thermodynamic properties, such as the potential mean force, show
that the interaction between capsaicin and chitosan polymers is very weak com-
pared to that with lecithin. Besides, an association between capsaicin and chitosan
in presence of lecithin is not likely to occur. In this work, we managed to combine
the power of the DPD method with the power of the GPUs. The simulations
reported have been the longest so far by regarding the encapsulation of capsaicin by
liposomal nanoparticles.
Continuing with our research computational about self-assembly of molecular
components for the design of bionanomaterials focused on drug delivery applica-
tions, the objective of this chapter is to show the advantages offered by the
DPD technique to study the self-assembly mechanism of liposomes. As a specific
case study, we show the formation of liposomes loaded with capsaicin. Capsaicin,
a lipophilic drug, is the pungent vanilloid compound in spicy chili peppers. We
chose capsaicin because it is approved as a drug for the treatment of chronic pains
[32]. It is also an excellent candidate to be transported by natural polymers such as
chitosan [33]. In addition, it is widely recognized in the treatment of urological
disorders and the control of satiety and obesity [34], among other important
applications.
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2. Dissipative particle dynamic foundations
2.1 Theoretical formulation
The simulation of DPD is one of the most viable methods to study thermody-
namic and structural properties of biophysical processes at mesoscopic time and
length scales, unlike the simulation with MD, where insights at microscopic
time and length scales can achieved. This great advantage of DPD simulation is
that the DPD models are built under the coarse-grained scheme, which is
obtained from the description of all-atom of a given system. This coarse-graining
parameter plays a vital role and has significant impact on the speed of simulation
[35]. This feature makes the DPD simulations cheap and very fast computationally
speaking.
The theoretical foundations of the DPD method are documented elsewhere.
Readers interested can consult the following references [36-40] for more specific
details. In this chapter, we will mention in a very summarized way the main
mathematical aspects that govern the equations of this methodology. The DPD was
introduced by Hoogerbrugge and Koelman in 1992 [41] for simulations of hydro-
dynamic phenomena. It was subsequently modified by Español and Warren in 1995
[42] who introduced the fluctuation-dissipation theorem in the original algorithm
to add the frictional and stochastic forces. Therefore, a coupling between the statis-
tical mechanic laws of the beads and Gibbs canonical ensemble is given, favoring
the calculation of thermodynamic properties at longer time and length scales. Sim-
ilar to molecular dynamics, the time evolution of each DPD particle can be calcu-
lated by Newton’s second law:
dri
dt
¼ vi, dpidt ¼ ∑j6¼i
Fij (1)
where ri, vi, and pi are respectively the position, velocity, and momentum
vectors of particle i, and Fij is the total interparticle force exerted on particle i by
particle j. Specifically, Fij ¼ FCij þ FRij þ FRij , where a purely repulsive conservative
force FCij , a dissipative or frictional force F
R
ij , which represents the effects of viscosity
and slows down the particle motion with respect to each other, and a random
(stochastic) force FRij , which represents the thermal or vibrational energy of system,





rij rij < rc
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where eij ¼ rij=rij, rij ¼ ri � rj, rij ¼ ri � rj
�� ��, and vij ¼ vi � vj





are the distance-dependent weight functions for the dissipative
force and random force, respectively. The symbols aij, γ, and σ determine the
strength of conservative, random, and dissipative forces, respectively. Moreover,
in order to generate a correct equilibrium Gibbs-Boltzmann distribution, the
dissipative and random forces have to satisfy the following relations:
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wD rij
� � ¼ wR rij
� �� �2
, σ2 ¼ 2γkBT (3)
where kB is the Boltzmann constant. According to Groot and Warren [43], we
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Technically, DPD simulation differs from MD simulation in two respects. First,
the conservative pairwise forces between DPD particles are soft-repulsive, which
makes it possible to extend the simulations to longer time scales. Second, the
scheme to maintain constant temperature in DPD is implemented in terms of
dissipative as well as random pairwise forces such that the momentum is locally
conserved, which results in the emergence of hydrodynamic flow effects on the
macroscopic scale.
2.2 Mesoscopic model of liposomes
From the molecular point of view, a liposome, which is usually amphiphilic
molecules, contains polar heads and hydrophobic hydrocarbon tails. This molecular
structure is ideal to build a DPD model, since the polar part can be grouped in a
single bead, while the hydrophobic part can be grouped in another bead. The
liposome presented in this work is constituted by lecithin, which has two long
hydrocarbon chains, is a major component of lipid bilayers of cell membranes and is
a natural and biological amphiphile. Lecithin is a natural lipid mixture of phospho-
lipids used frequently for the preparation of various nanosystem delivery vehicles,
such as liposomes [9, 10]. According to the molecular structure of lecithin, this can
be separated into three different beads that correspond to the head, neck, and tail
groups, respectively. A schematic illustration of the fundamental self-assembly of
the structure of a liposome adopted in this chapter is shown in Figure 1. In
Figure 1A, a detailed molecular description at all-atom level for the lipid is shown; a
mapping in the bead representation of the atomistic structure is also shown.
Figure 1B is depicting the coarse-grained model of lecithin used in this work with
its three fundamental parts. A snapshot of configurational structure of the liposome
constructed based on lecithin is shown in Figure 1C. From this representation, the
yellow spheres represent the hydrophobic part of the lecithin, while the red spheres
represent the hydrophilic part.
On the other hand, we show the coarse-grained model of capsaicin, our target as
case of study in drug delivery applications. The molecular structure of capsaicin is
also ideal for building a DPD model. Similar to lecithin, the capsaicin can be
grouped into three groups or beads, i.e., one bead for the head, neck, and tail
groups, respectively. Figure 1A shows the coarse-grained model for capsaicin.
Finally, in Figure 1A, we show the coarse-grained model of water. This model in
DPD simulation is already well known; for example, a bead DPD can group up to
three water molecules. This model allows to conserve the thermodynamic proper-
ties of water.
2.3 Computational details of mesoscopic simulations
Mesoscopic simulations were performed to study the self-assembling of lipo-
somes. The capsaicin was used as an example of drug delivery applications. For this
end, the simulations presented in this work were made under canonical ensemble,
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where N (the total particle number), V (volume), and T (temperature) are kept
constant. For this type of simulations at constant temperature, some parameters
must be specified. In this work, in all the simulations, we use dimensionless units or
DPD units, i.e., the temperature and density were of T = 1.0, ρ = 3.0, respectively,
the mass of all particles is m ¼ 1:0. The system studied (liposome in aqueous
solution) is constituted by 1000, 2000, 3000, 4000, and 5000 molecules of lecithin;
each lecithin is constituted by three beads as shown in Figure 1; the remaining
particles form part of solvent or water molecules. A total of 200,000 DPD particles
were simulated. The simulation cell has a length of 40 DPD units. In DPD simula-
tions, a key factor to carry them out is the specification of the parameters of
interaction between the different components that make up a given system; this is
due to the presence of the conservative forces in Eq. (3). The DPD interaction
matrix for each type of bead used in this chapter is shown in Table 1.
The nomenclature used in this table goes as follows: the symbols L1, L2, and L3
represent the head, neck, and tail beads of lecithin, while that W symbol represents
the bead corresponding the beads of water.
On the other hand, the parameters of intramolecular interactions in lecithin are
r0 ¼ 0:7 and kr ¼ 100:0 for the bonds between two particles [44], while for angles
between three particles, it is taken θ0 ¼ 170:0 and kθ ¼ 50:0. Finally, the cutoff
radius is taken as rc ¼ 1:0; the parameters σ and γ of the dissipative and random
forces are equal to 3.0 and 4.5, respectively, parameters that appear in Eq. (2). The
Figure 1.
Schematic illustration of computational models used for self-assembly of liposomes, from atomistic to mesoscopic
representation. (A) Example of a lipid in a representation of all-atom. The computational model of coarse
grain is constructed by grouping certain functional groups that form the fundamental molecular structure. In
this case, the 35 atoms of the molecular structure of the phospholipid are grouped into only five sites or pseudo-
atoms of coarse-grained type. (B) Example of our coarse-grained model of a lipid. The red spheres represent the
hydrophobic group, while yellow spheres represent the hydrophilic group. (C) A representation of a liposome
showing the inner of aqueous nucleus.
L1 L2 L3 W
L1 78.0 80.0 95.0 89.0
L2 80.0 78.0 86.0 93.0
L3 95.0 86.0 78.0 101.0
W 89.0 93.0 101.0 78.0
Table 1.
Matrix interaction aij according to Eq. (2).
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integration time step is Δt ¼ 0:03, and the simulations are running over the 100
blocks of 10,000 steps every block, having a total of 1 � 106 steps, to reach a total of
4.8 μs. This simulation time is long enough to observe the self-assembly of the
liposomes. With a traditional MD, the use of large supercomputing clusters is
required to obtain this time scale. The equations of motion are solved using the
velocity Verlet algorithm adapted to DPD [45]. The presence of electric charges was
not considered in these calculations.
3. Drug delivery applications through numerical experiments
For the study of self-assemblies of liposomes for drug delivery applications,
three different processes are presented. First, we analyze lipid self-assembly. Sec-
ond, self-assembly of capsaicin is presented. Third, we end with the analysis of
self-assembly of capsaicin by lecithin. The formation of nanoliposomes was
explored by varying the concentration of both lecithin and capsaicin molecules
separately. These simulations were analyzed through its density maps. This prop-
erty is very useful for refining structures or adjusting molecular models; besides,
the density maps allow us to spatially inspect the average location of atoms of
interest during a simulation [46].
3.1 Exploring self-assemblies of lipids
To explore the self-assemblies of lipids, the density maps of five different pro-
cesses were obtained. In these processes, the effect of lipid concentration was
explored. Figure 2 shows the snapshots of each of these processes. We observe that
in Figure 2A, with a concentration of 1000 lipid molecules, the self-association of
lipids is practically negligible. Only a slight formation of small clusters is perceived,
similar to the density maps of very diluted solutions. By increasing the concentra-
tion of lipids to double, that is, to 2000 molecules as can be seen in Figure 2B, we
observe that the association increases with respect to the previous case of 1000 lipid
molecules. However, it is not yet a sufficient concentration to detect any indication
of the process of self-assembly of lipids. Figure 2C shows the case for a concentra-
tion of 3000 lipid molecules. In this system, the formation of very faint regions is
observed. The presence of these very light red dots is an indication that the lipids
begin to self-assemble. To verify that the lipid molecules are indeed self-assembling,
a simulation with 4000 lipid molecules was carried out. The result is shown in
Figure 2D. As we expected, the formation of the red dots increases, and they begin
Figure 2.
Density maps for exploring the self-assembly of lipids. (A) 1000 lipid molecules, (B) 2000 lipid molecules, (C)
3000 lipid molecules, (D) 4000 lipid molecules, and (E) 5000 lipid molecules. Below each density map, a
snapshot of the final configuration is displayed using the same color code as Figure 1. The solvent molecules are
not shown for clarity purposes.
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self-assembly of capsaicin by lecithin. The formation of nanoliposomes was
explored by varying the concentration of both lecithin and capsaicin molecules
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the density maps allow us to spatially inspect the average location of atoms of
interest during a simulation [46].
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more notoriously. To observe the stability in the formation of lipids, a simulation
with 5000 molecules was carried out. At this concentration, the lipid association is
already clearly observed. A picture of this system is seen in Figure 2E. The red
regions show that the self-assembly process has already taken place. These are the
optimal conditions in terms of concentration for the process of self-assembly of
lipids to be carried out. For higher concentrations of lipids, greater than 5000
molecules, we will find a saturation of the system, which is an amount sufficient for
the formation of a nanoliposome. An animation video of each of these systems can
be found in the supplementary material section of this work.
3.2 Exploring self-assemblies of capsaicin
We conducted an exploration to study the self-assembly of capsaicin. For this
purpose, we carried out four separate numerical experiments. The results of these
simulations are found in Figure 3, analyzed through their density maps. These maps
show regions of high and low density basically. The regions of low density are the
ones that predominate the colors black and purple, while the regions of high density
are those that are identified in lighter shades such as red or yellow. Figure 3A shows
the density map for a system composed of 250 capsaicin molecules. Due to the low
concentration of capsaicin molecules, the black and purple regions predominate,
which are located in a density range between 0.02 and 0.04. In the second numer-
ical experiment, we doubled the concentration of capsaicin molecules. Figure 3B
shows the density maps for this system composed of 500 capsaicin molecules. The
presence of regions in all reddish is notorious, which oscillates between 0.08 and
0.12 in density. However, purple regions are still observed, which indicate that this
Figure 3.
Density maps for exploring the self-assembly of capsaicin. These snapshots correspond to equilibrated systems
composed of (A) 250 capsaicin molecules, (B) 500 capsaicin molecules, (C) 750 capsaicin molecules, and (D)
1000 capsaicin molecules.
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concentration of capsaicin molecules is not yet enough to have a homogenous
system. Figure 3C shows the density map for a system composed of 750 capsaicin
molecules. Unlike the density map of Figure 3B, the presence of purple areas is
already minimal, while the presence of high-density areas is more consolidated. A
higher density of capsaicin molecules is necessary to completely eliminate the
purple areas. This can be seen in Figure 3D, which shows the density map for a
concentration of 1000 capsaicin molecules. Note in this case how the purple areas
have completely disappeared. The entire density map is in a homogenous system
with a density that ranges between 0.2 and 0.25. This concentration of capsaicin
molecules is optimal for use in the process of formation of nanoliposomes.
3.3 Exploring self-assembly of capsaicin by lecithin nanoliposomes
We have documented that nanoliposomes are effective for the drug delivery
process. A strategic requirement for the supply of medicines to a specific site has
driven the development of active drug targeting techniques [47]. In this way, to
take advantage of the effective potential of the liposome technology and the impact
on its formulations, it is necessary to know the optimal conditions in terms of
concentration of each of the components that are required for an optimal applica-
tion of any given drug. To explore the self-assembly of capsaicin by means of
lecithin liposomes, we conducted four numerical experiments. The number of
capsaicin molecules used in these four experiments was 250, 500, 750, and 1000
corresponding to a concentration of 30, 61, 92, and 123 mM, respectively, and the
concentration of lecithin remained constant with 5000 molecules in the four cases.
Figure 4 shows the density maps obtained for these four cases. Figure 4A–D shows
the density maps for a system loaded with 250, 500, 750, and 1000 capsaicin
molecules. For all four we observed a homogeneous formation of the liposome. The
Figure 4.
Density maps for exploring self-assembly of capsaicin by lecithin nanoliposomes. These snapshots correspond to
equilibrated systems composed of (A) 250 capsaicin molecules, (B) 500 capsaicin molecules, (C) 750 capsaicin
molecules, and (D) 1000 capsaicin molecules.
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more notoriously. To observe the stability in the formation of lipids, a simulation
with 5000 molecules was carried out. At this concentration, the lipid association is
already clearly observed. A picture of this system is seen in Figure 2E. The red
regions show that the self-assembly process has already taken place. These are the
optimal conditions in terms of concentration for the process of self-assembly of
lipids to be carried out. For higher concentrations of lipids, greater than 5000
molecules, we will find a saturation of the system, which is an amount sufficient for
the formation of a nanoliposome. An animation video of each of these systems can
be found in the supplementary material section of this work.
3.2 Exploring self-assemblies of capsaicin
We conducted an exploration to study the self-assembly of capsaicin. For this
purpose, we carried out four separate numerical experiments. The results of these
simulations are found in Figure 3, analyzed through their density maps. These maps
show regions of high and low density basically. The regions of low density are the
ones that predominate the colors black and purple, while the regions of high density
are those that are identified in lighter shades such as red or yellow. Figure 3A shows
the density map for a system composed of 250 capsaicin molecules. Due to the low
concentration of capsaicin molecules, the black and purple regions predominate,
which are located in a density range between 0.02 and 0.04. In the second numer-
ical experiment, we doubled the concentration of capsaicin molecules. Figure 3B
shows the density maps for this system composed of 500 capsaicin molecules. The
presence of regions in all reddish is notorious, which oscillates between 0.08 and
0.12 in density. However, purple regions are still observed, which indicate that this
Figure 3.
Density maps for exploring the self-assembly of capsaicin. These snapshots correspond to equilibrated systems
composed of (A) 250 capsaicin molecules, (B) 500 capsaicin molecules, (C) 750 capsaicin molecules, and (D)
1000 capsaicin molecules.
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concentration of capsaicin molecules is not yet enough to have a homogenous
system. Figure 3C shows the density map for a system composed of 750 capsaicin
molecules. Unlike the density map of Figure 3B, the presence of purple areas is
already minimal, while the presence of high-density areas is more consolidated. A
higher density of capsaicin molecules is necessary to completely eliminate the
purple areas. This can be seen in Figure 3D, which shows the density map for a
concentration of 1000 capsaicin molecules. Note in this case how the purple areas
have completely disappeared. The entire density map is in a homogenous system
with a density that ranges between 0.2 and 0.25. This concentration of capsaicin
molecules is optimal for use in the process of formation of nanoliposomes.
3.3 Exploring self-assembly of capsaicin by lecithin nanoliposomes
We have documented that nanoliposomes are effective for the drug delivery
process. A strategic requirement for the supply of medicines to a specific site has
driven the development of active drug targeting techniques [47]. In this way, to
take advantage of the effective potential of the liposome technology and the impact
on its formulations, it is necessary to know the optimal conditions in terms of
concentration of each of the components that are required for an optimal applica-
tion of any given drug. To explore the self-assembly of capsaicin by means of
lecithin liposomes, we conducted four numerical experiments. The number of
capsaicin molecules used in these four experiments was 250, 500, 750, and 1000
corresponding to a concentration of 30, 61, 92, and 123 mM, respectively, and the
concentration of lecithin remained constant with 5000 molecules in the four cases.
Figure 4 shows the density maps obtained for these four cases. Figure 4A–D shows
the density maps for a system loaded with 250, 500, 750, and 1000 capsaicin
molecules. For all four we observed a homogeneous formation of the liposome. The
Figure 4.
Density maps for exploring self-assembly of capsaicin by lecithin nanoliposomes. These snapshots correspond to
equilibrated systems composed of (A) 250 capsaicin molecules, (B) 500 capsaicin molecules, (C) 750 capsaicin
molecules, and (D) 1000 capsaicin molecules.
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high-density regions are representing the region formed by the lipid membrane,
which in this case is presented as the region with the highest concentration (in
yellow) in the four cases. In addition, in the four cases, they present a redder region
in the center of the map; this indicates that the density of the lipids is lower, as
expected. Density maps also show that the nanoliposome is stable for 4.8 μs of
simulation, since the lecithin molecules do not spread throughout the simulation
box nor do they collapse in the aqueous core to form a micelle; this was possible
thanks to the previous analysis where we found the optimal concentration of
lecithin molecules in the self-assembly process.
In our previous study [31], we observed the formation of a nanoliposome based
on lecithin was carried out with approximately 7000 molecules of lecithin, but in
that study, the presence of natural polymers such as chitosan was included, a
component that is not present in these simulations.
Derived from the results obtained in the density maps of Figure 4, we
proceeded to make an analysis on the encapsulation efficiency (EE). It has been
reported that both size and EE are key variables in the preparation of liposomes
[47]. However, these variables are difficult to control at the laboratory level even
with sophisticated experimental equipment. Computational tools such as DPD are
ideal for guiding experiments. The size and EE for the system analyzed in this work
are show in Table 2. EE is obtained from the following equation: EE = ((CapsT 
CapsF)/CapsT)  100, where CapsT is the total concentration of capsaicin in the
system and CapsF is the free capsaicin in solution. The percentage of EE for the
capsaicin obtained in this work was of 96%, which is very close to that reported
experimentally of 92% [48], besides, is very similar to the obtained percentage in
our previous study, where the presence of chitosan polymer was included [31].
4. Conclusions
In this chapter, simulations at the mesoscopic scale were used to systematically
study the self-assembly of liposomes and their potential applications toward the
delivery of drugs. The advantages offered by the mesoscopic methods such as DPD
over other simulation methods such as MD were exposed; additionally, the acceler-
ation that the DPD simulations have achieved through the new GPUs technologies
was also covered. With these technologies, we show simulations in the microsecond
scale with a system composed of 150,000 particles in the process of self-assembly of
liposomes. We show the optimal conditions for the formation of liposomes in
function of the lecithin concentration to achieve a good capsaicin encapsulation.
Our percentage of EE obtained is quite acceptable with respect to experimental
measurements and simulation studies of similar systems.
Concentration of capsaicin (Mn) Size (nm)  (nm) EE (%)  (%)
30 17.95 0.46 96.27 0.69
61 18.01 0.61 96.93 0.36
92 17.90 0.21 96.81 0.35
123 17.97 0.16 96.94 0.25
Table 2.
Mean size of the nanoliposome and encapsulation efficiency (EE) as a function of concentration of capsaicin.
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component that is not present in these simulations.
Derived from the results obtained in the density maps of Figure 4, we
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reported that both size and EE are key variables in the preparation of liposomes
[47]. However, these variables are difficult to control at the laboratory level even
with sophisticated experimental equipment. Computational tools such as DPD are
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system and CapsF is the free capsaicin in solution. The percentage of EE for the
capsaicin obtained in this work was of 96%, which is very close to that reported
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study the self-assembly of liposomes and their potential applications toward the
delivery of drugs. The advantages offered by the mesoscopic methods such as DPD
over other simulation methods such as MD were exposed; additionally, the acceler-
ation that the DPD simulations have achieved through the new GPUs technologies
was also covered. With these technologies, we show simulations in the microsecond
scale with a system composed of 150,000 particles in the process of self-assembly of
liposomes. We show the optimal conditions for the formation of liposomes in
function of the lecithin concentration to achieve a good capsaicin encapsulation.
Our percentage of EE obtained is quite acceptable with respect to experimental
measurements and simulation studies of similar systems.
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Abstract
Quality by Design (QbD) is a systematic, risk-based approach to pharmaceutical 
product and manufacturing development, which uses quality-improving scientific 
methods upstream in the research, development, and design phases, in order to 
assure that quality and safety are designed into product at as early stage as possible. 
This work focuses on the state-of-the-art applications of the QbD principles in 
the development of liposomes. The QbD approach has recently been proposed as 
a useful tool to obtain higher-quality liposomal products, as their development is 
a challenging task, involving intricate formulation and manufacturing processes. 
Thus, the current strategies to define the relationship between the critical mate-
rial attributes or process parameters and product critical quality attributes and to 
establish the design space are overviewed. Additionally, the current characteriza-
tion methodologies are described, as part of the control strategy required within the 
QbD paradigm.
Keywords: liposomes, Quality by Design, critical quality attributes, design space, 
quality control
1. Introduction
In the recent years, the Quality by Design (QbD) concept has gained importance 
in drug development and drug manufacturing. QbD is recommended by the drug 
regulatory agencies (FDA—Food and Drug Administration and EMA—European 
Medicines Agency) to improve the quality of pharmaceutical products.
For the pharmaceutical products, quality is regarded as a mandatory topic 
and must be assured for all. Pharmaceutical products’ quality is ensured through 
the ability to get the therapeutic benefit mentioned on the label and through the 
absence of contamination [1, 2]. Product quality refers to performance, robustness, 
trustworthiness, and has to be built into it [3]. To ensure the quality of a product, 
scientific approaches such as QbD can be implemented. The concept of QbD was 
first defined a few decades ago by Dr. Joseph M. Juran, a well-known pioneer of 
quality, and emphasizes the design of a product and manufacturing process to reach 
a certain predefined quality [1, 2, 4]. According to Dr. Juran, quality should be built 
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1. Introduction
In the recent years, the Quality by Design (QbD) concept has gained importance 
in drug development and drug manufacturing. QbD is recommended by the drug 
regulatory agencies (FDA—Food and Drug Administration and EMA—European 
Medicines Agency) to improve the quality of pharmaceutical products.
For the pharmaceutical products, quality is regarded as a mandatory topic 
and must be assured for all. Pharmaceutical products’ quality is ensured through 
the ability to get the therapeutic benefit mentioned on the label and through the 
absence of contamination [1, 2]. Product quality refers to performance, robustness, 
trustworthiness, and has to be built into it [3]. To ensure the quality of a product, 
scientific approaches such as QbD can be implemented. The concept of QbD was 
first defined a few decades ago by Dr. Joseph M. Juran, a well-known pioneer of 
quality, and emphasizes the design of a product and manufacturing process to reach 
a certain predefined quality [1, 2, 4]. According to Dr. Juran, quality should be built 
into a product, and the way in which a product is designed is accountable for most 
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issues related to its quality. Dr. Juran believed that the quality of a product could 
be planned and the most quality inadequacies originate from the way in which the 
quality of the product was planned [4, 5].
In the pharmaceutical field, there are several regulatory guidelines developed 
by ICH, FDA, and EMA, which offer the necessary information in understanding 
how the QbD concept may be implemented [2, 3, 6–8]. In ICH Q8—Pharmaceutical 
Development guideline, QbD is defined as “a systematic approach to develop-
ment that begins with predefined objectives and emphasizes product and process 
understanding and process control, based on sound science and quality risk man-
agement” [9]. Such a scientific, risk-based, and pro-active approach from the devel-
opment to manufacturing of a pharmaceutical product will provide the necessary 
knowledge and information to minimize the risk and ensure a predefinite quality 
of the product [10]. So, QbD provides the tool to understand the way in which the 
quality of a pharmaceutical product is influenced by formulation, input materials’ 
characteristics, and process variables; therefore, the quality of the product can be 
ensured by controlling the formulation input materials and the manufacturing 
process key variables [2, 4, 11]. It involves designing a formulation and manufactur-
ing process in such a way to obtain a pharmaceutical product with predetermined 
quality specifications [12]. QbD identifies characteristics that are critical to quality 
of the product, translates them into attributes that the drug should possess, and 
establishes how the critical formulation and process parameters can be varied to 
constantly produce a drug product with the desired characteristics [13, 14]. The 
goal of the QbD approach is in-depth understanding of the formulation and process 
variables, and of the relationship between them, in order to obtain a drug product 
with consistent desired characteristics [15, 16]. Practically, QbD helps establishing 
the critical quality attributes (CQAs) of the product and how the critical mate-
rial attributes (CMAs) and critical process parameters (CPPs) can be modified to 
deliver a product with predetermined quality specifications [12].
A QbD approach includes several key steps, as follows: (1) defining the qual-
ity target product profile (QTPP); (2) performing a risk assessment, in order to 
identify which formulation, material, or process parameters can potentially influ-
ence the product’s quality attributes (CQAs); (3) studying the impact of the formu-
lation variables, material attributes, and process parameters on the critical quality 
attributes (CQAs) of the drug product, and finding which of them are critical 
material attributes (CMAs) and critical process parameters (CPPs); (4) establishing 
a design space that ensures desired product specifications; and (5) designing and 
implementing a control strategy in order to ensure a continuous improvement [9, 
17, 18]. In order to study the relationship between the CMAs and CPPs and their 
impact on CQAs in a mathematical form, the Design of Experiments (DoE) strategy 
is used. This method also allows to establish the design space by running a mini-
mum number of experiments [2, 11, 19]. The design space for liposome preparation 
may be established by implementing the QbD strategy as a systematic approach in 
liposome development, in order to improve the product quality, by understanding 
and controlling formulation, materials, and manufacturing variables. The strategy 
is recommended by the drug regulatory agencies for the development of better-
quality products and may be used in liposomal drug product development.
2.  Defining the QTPP for liposomal products and identification of the 
CQAs
The most important element in using QbD concept to assist formulation and 
process design is to predefine the desired final product quality profile [9, 14, 20]. 
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According to the definition of ICH, the QTPP is “a prospective summary of the 
quality characteristics of a drug product that ideally will be achieved to ensure the 
desired quality, taking into account safety and efficiency of the drug product” [9]. 
In order to establish the QTPP, the following considerations must be taken into 
account: route of administration, dosage form, dosage strength, delivery system, 
attributes affecting pharmacokinetic characteristics, stability, sterility, and drug 
release appropriate for the intended final product [14, 20].
QTPP is established based on prior scientific knowledge and appropriate in vivo 
relevance. According to the current flux of literature, a QTPP for liposomal prod-
ucts is presented in Table 1 along with the targets for each element [21].
When designing a nanoformulation, the efficiency of the final product will be 
directly related to particle size. Particle size is the most important factor influencing 
biodistribution, circulation half-life, and cellular uptake. Due to their small size 
and large surface area, pharmaceutical nanosystems show enhanced bioavailability 
and additional ability to cross the biological membranes. Furthermore, in cancer 
therapy, smart nanoparticles deliver the drug into the tumor tissue and avoid nor-
mal tissues and organs [22]. After intravenous administration, liposomes accumu-
late in tumors by a passive or active targeting, for determining higher therapeutic 
efficiency and less side effects [23]. As a parenteral dosage form, liposomal products 
must be sterile, pyrogen free, and well tolerated [24]. The lack of hemolytic activity 
is also mentioned as requirement for liposome products [25].
The second step in a QbD approach is the identification of CQAs. According to 
ICH Q8 definition, a CQA is a “physical, chemical, biological, or microbiological 
property or characteristic that should be within an appropriate limit, range, or 
distribution to ensure the desired product quality.” They are either derived from the 
QTPP or defined based on regulatory requirements and review of the literature [9].
Based on these recommendations, for the liposomal products the following 
CQAs are usually identified: mean particle size, size distribution, and zeta potential 
(as physical CQAs); drug content (as chemical CQAs); in vivo stability and drug 
release (as biological CQAs); sterility (as microbiological CQA).
a. Generally, for all nanoparticles, the mean particle size and particle size distribu-
tion are major CQAs, which play an important role in determining their in vivo 
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The biodistribution of nanoparticles circulating in the blood stream is con-
siderably influenced by particle size. Smaller particles, of 20–30 nm, are 
eliminated by kidneys, while larger particles, of up to 300 nm, are taken up 
by reticuloendothelial system (RES) [26]. By decreasing particle size below 
100 nm, RES uptake can be reduced [27]. According to other studies, the ideal 
nanocarriers should have particle size ranging between 10 and 100 nm in 
order to evade the kidney filtration and capture by the liver [28]. For example, 
in tumor targeting, the particles need to be smaller than the cut-off of the 
fenestrations in the tumor neovasculature [29]. The literature reveals that for 
an efficient enhanced permeability and retention (EPR) effect, the particle 
size must be, generally, between 50 and 100 nm, depending on the tumor 
type, its environment, and its localization [28]. Particle size less than 200 nm 
is also beneficial for the sterility of the liposomal product, since this size allows 
aseptic preparation and sterile filtration of the final product [30].
Particle size also influences the kinetics of drug release. As particle size gets 
smaller, their surface area-to-volume ratio gets larger. This would imply that 
more of the drug is closer to the surface of the particle compared to a larger 
particle. Being at or near the surface would lead to a faster drug release [23].
Polydispersity index, reflecting particle size distribution of liposomal prod-
ucts, is a physical parameter for which the target is to have reduced values, 
indicating a good homogeneity of the dispersion. Generally, polydispersity 
index values below 0.5 are reported to be acceptable [31].
b. Zeta potential or particle charge is an important parameter in the evaluation 
of colloidal system’s stability. Particles with a high negative or positive zeta 
potential value repel each other, indicating that the colloidal system is stable 
[32]. On the contrary, decreasing the zeta potential value to nearly neutral 
leads to liposomal aggregation [20]. The charge of nanosystems influences 
both systemic circulation time and the interactions with the target tissue. The 
presence of surface charge can alter the opsonization profile of the particles, its 
recognition by cells in the organs of the RES, and the overall plasma circulation 
profile [29]. Regarding the interaction with the target, it is known that cationic 
liposomes have affinity for negatively charged cancer cell membrane and 
higher selectivity than neutral or anionic liposomes. The intracellular uptake 
of cationic liposomes by tumor cells can be 14-fold higher than that of normal 
liposomes. Consequently, cationic liposomes enhance the safety of liposomal 
drug. The liposome charge can also influence drug loading, cationic liposomes 
exhibiting higher encapsulation efficiency for negatively charged drugs [32].
c. Depending on drug distribution in liposomal dispersion, the drug content of 
liposomes can be expressed in three ways: drug concentration (μg/mL); entrap-
ment efficiency (EE, the amount of drug contained inside liposomes compared 
with total amount of drug; %); and drug loading (the amount of drug con-
tained relative to the amount of the lipid used; drug-to-lipid ratio) [14, 20].
High encapsulation efficiency is very important for both manufacturers 
and patients. A higher percentage of drug encapsulation could reduce the 
manufacturing cost and increase drug concentration in the final formulation 
allowing greater flexibility in dosing. Depending on the pharmacokinetics, 
higher drug concentration can result in increased dosing intervals and hence 
improved patient compliance [30].
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Drug retention inside liposomes is also very important. Since liposomes are 
intended to deliver the drug to the target site, there should be no drug leakage 
until cellular uptake [30].
d. In order to have a prolonged drug release and an efficient tumor accumulation 
by passive targeting, in vivo stability is essential. In vivo behavior of liposomes 
after intravenous administration is directly linked to their interaction with blood 
components, which depends on the hydrophobic/hydrophilic character of lipo-
some surface. The more hydrophobic a nanoparticle is, the more likely it is to be 
cleared by phagocytosis, due to higher binding of blood proteins (opsonization) 
[22]. The improved surface properties are associated with the steric hindrance 
effect offered by hydrophilic polymers, which can prevent the surface-modified 
liposomes from being rapidly eliminated by RES (“stealth liposomes”). 
Hydrophilization of liposome surface prolongs circulation time (long-circulat-
ing liposomes), enhancing the therapeutic potential of the entrapped drug [33].
e. Drug release kinetics has important implication for the therapeutic activity of 
liposomes. The drug must be delivered to the disease site at a level within its 
therapeutic window, at a sufficient rate, for a sufficient period, to have optimal 
therapeutic activity [34]. Drug delivery to the right site is related to the iden-
tification and the interaction with the target cells. Cell surface or blood vessel 
surface of tumor tissues has a series of specific and overexpressed receptors, 
which are closely related with tumor process [33]. Targeting ligands attached 
on liposomes’ surface bind the corresponding receptors and, as a result, the 
liposomes are internalized by endocytosis. These ligands can be monoclonal 
antibodies, fragments of antibodies, peptides, proteins, nucleic acids, carbohy-
drates, or small molecules [29].
3.  The critical material attributes and critical process parameters: 
identification and linking to CQAs
All the material attributes (MAs) and/or process parameters (PPs) that can 
affect the desired critical quality attributes (CQAs) of the final/intermediate prod-
uct are identified through risk assessment. After risk identification, risk analysis 
evaluates the impact of the identified MAs and PPs on the CQAs. Further, through 
risk evaluation, a qualitative or quantitative scale is used for risk estimation of each 
identified factor on the desired CQA [35]. After the risk evaluation of potential MAs 
and PPs, only few of them will become potentially critical for quality attributes of 
the final drug product. In this case, identified MAs will become critical material 
attributes (CMAs), which must possess certain characteristics or should be chosen 
in an appropriate range to assure CQAs of the intermediate/final drug product 
[21]. Critical process parameters (CPPs) are those PPs that should be monitored 
and controlled in order to obtain the desired CQAs of the intermediate/final drug 
product [9]. Many tools are used for risk assessment, but the most used ones are 
Ishikawa or fish-bone diagram for risk identification and failure mode and effect 
analysis for risk evaluation [36]. Risk assessment should be done in the first step of 
the drug product development, and analysis of these risk factors is recommended to 
be reconsidered during different stages of the drug development [37].
To establish the CMAs, the main components of liposomes are evaluated, that 
is the active substance, the lipids, and others like buffer solution [38]. Each active 
substance has different physiochemical properties and can influence the desired 
CQAs [9, 39]. Depending on its solubility, it can be entrapped in the aqueous core 
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The biodistribution of nanoparticles circulating in the blood stream is con-
siderably influenced by particle size. Smaller particles, of 20–30 nm, are 
eliminated by kidneys, while larger particles, of up to 300 nm, are taken up 
by reticuloendothelial system (RES) [26]. By decreasing particle size below 
100 nm, RES uptake can be reduced [27]. According to other studies, the ideal 
nanocarriers should have particle size ranging between 10 and 100 nm in 
order to evade the kidney filtration and capture by the liver [28]. For example, 
in tumor targeting, the particles need to be smaller than the cut-off of the 
fenestrations in the tumor neovasculature [29]. The literature reveals that for 
an efficient enhanced permeability and retention (EPR) effect, the particle 
size must be, generally, between 50 and 100 nm, depending on the tumor 
type, its environment, and its localization [28]. Particle size less than 200 nm 
is also beneficial for the sterility of the liposomal product, since this size allows 
aseptic preparation and sterile filtration of the final product [30].
Particle size also influences the kinetics of drug release. As particle size gets 
smaller, their surface area-to-volume ratio gets larger. This would imply that 
more of the drug is closer to the surface of the particle compared to a larger 
particle. Being at or near the surface would lead to a faster drug release [23].
Polydispersity index, reflecting particle size distribution of liposomal prod-
ucts, is a physical parameter for which the target is to have reduced values, 
indicating a good homogeneity of the dispersion. Generally, polydispersity 
index values below 0.5 are reported to be acceptable [31].
b. Zeta potential or particle charge is an important parameter in the evaluation 
of colloidal system’s stability. Particles with a high negative or positive zeta 
potential value repel each other, indicating that the colloidal system is stable 
[32]. On the contrary, decreasing the zeta potential value to nearly neutral 
leads to liposomal aggregation [20]. The charge of nanosystems influences 
both systemic circulation time and the interactions with the target tissue. The 
presence of surface charge can alter the opsonization profile of the particles, its 
recognition by cells in the organs of the RES, and the overall plasma circulation 
profile [29]. Regarding the interaction with the target, it is known that cationic 
liposomes have affinity for negatively charged cancer cell membrane and 
higher selectivity than neutral or anionic liposomes. The intracellular uptake 
of cationic liposomes by tumor cells can be 14-fold higher than that of normal 
liposomes. Consequently, cationic liposomes enhance the safety of liposomal 
drug. The liposome charge can also influence drug loading, cationic liposomes 
exhibiting higher encapsulation efficiency for negatively charged drugs [32].
c. Depending on drug distribution in liposomal dispersion, the drug content of 
liposomes can be expressed in three ways: drug concentration (μg/mL); entrap-
ment efficiency (EE, the amount of drug contained inside liposomes compared 
with total amount of drug; %); and drug loading (the amount of drug con-
tained relative to the amount of the lipid used; drug-to-lipid ratio) [14, 20].
High encapsulation efficiency is very important for both manufacturers 
and patients. A higher percentage of drug encapsulation could reduce the 
manufacturing cost and increase drug concentration in the final formulation 
allowing greater flexibility in dosing. Depending on the pharmacokinetics, 
higher drug concentration can result in increased dosing intervals and hence 
improved patient compliance [30].
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Drug retention inside liposomes is also very important. Since liposomes are 
intended to deliver the drug to the target site, there should be no drug leakage 
until cellular uptake [30].
d. In order to have a prolonged drug release and an efficient tumor accumulation 
by passive targeting, in vivo stability is essential. In vivo behavior of liposomes 
after intravenous administration is directly linked to their interaction with blood 
components, which depends on the hydrophobic/hydrophilic character of lipo-
some surface. The more hydrophobic a nanoparticle is, the more likely it is to be 
cleared by phagocytosis, due to higher binding of blood proteins (opsonization) 
[22]. The improved surface properties are associated with the steric hindrance 
effect offered by hydrophilic polymers, which can prevent the surface-modified 
liposomes from being rapidly eliminated by RES (“stealth liposomes”). 
Hydrophilization of liposome surface prolongs circulation time (long-circulat-
ing liposomes), enhancing the therapeutic potential of the entrapped drug [33].
e. Drug release kinetics has important implication for the therapeutic activity of 
liposomes. The drug must be delivered to the disease site at a level within its 
therapeutic window, at a sufficient rate, for a sufficient period, to have optimal 
therapeutic activity [34]. Drug delivery to the right site is related to the iden-
tification and the interaction with the target cells. Cell surface or blood vessel 
surface of tumor tissues has a series of specific and overexpressed receptors, 
which are closely related with tumor process [33]. Targeting ligands attached 
on liposomes’ surface bind the corresponding receptors and, as a result, the 
liposomes are internalized by endocytosis. These ligands can be monoclonal 
antibodies, fragments of antibodies, peptides, proteins, nucleic acids, carbohy-
drates, or small molecules [29].
3.  The critical material attributes and critical process parameters: 
identification and linking to CQAs
All the material attributes (MAs) and/or process parameters (PPs) that can 
affect the desired critical quality attributes (CQAs) of the final/intermediate prod-
uct are identified through risk assessment. After risk identification, risk analysis 
evaluates the impact of the identified MAs and PPs on the CQAs. Further, through 
risk evaluation, a qualitative or quantitative scale is used for risk estimation of each 
identified factor on the desired CQA [35]. After the risk evaluation of potential MAs 
and PPs, only few of them will become potentially critical for quality attributes of 
the final drug product. In this case, identified MAs will become critical material 
attributes (CMAs), which must possess certain characteristics or should be chosen 
in an appropriate range to assure CQAs of the intermediate/final drug product 
[21]. Critical process parameters (CPPs) are those PPs that should be monitored 
and controlled in order to obtain the desired CQAs of the intermediate/final drug 
product [9]. Many tools are used for risk assessment, but the most used ones are 
Ishikawa or fish-bone diagram for risk identification and failure mode and effect 
analysis for risk evaluation [36]. Risk assessment should be done in the first step of 
the drug product development, and analysis of these risk factors is recommended to 
be reconsidered during different stages of the drug development [37].
To establish the CMAs, the main components of liposomes are evaluated, that 
is the active substance, the lipids, and others like buffer solution [38]. Each active 
substance has different physiochemical properties and can influence the desired 
CQAs [9, 39]. Depending on its solubility, it can be entrapped in the aqueous core 
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or in the lipid bilayer [40]. In order to achieve a greater therapeutic effect, more 
than one active substance may be encapsulated in the same product, so different 
physiochemical properties of one may influence the other/others drug entrapment 
process [40, 41]. Besides this, their octanol/buffer partition must also be taken into 
consideration because a low partition will lead to a prolonged release of the drug 
and vice versa [42].
Regarding the lipids, their physicochemical characteristics are also important. 
For example, lipids that contain unsaturated fatty acids are predisposed to degrada-
tion reactions like oxidation or hydrolysis and those which contain saturated fatty 
acids have a higher transition temperature (Tm) [43]. Another specific characteristic 
of lipids is their chain length. Usually, a shorter chain length will contribute to a 
thinner lipid bilayer and a larger internal volume for drug encapsulation. However, 
comparing three lipids with a difference of two carbon atoms between them, the 
lipid bilayer thickness obtained did not differ with more than 1 nm and a very small 
difference in liposomes’ size and EE was observed [30]. Lipid properties can have a 
great impact on liposomes’ membrane fluidity, permeability, or charge [44]. In this 
regard, cholesterol increases liposomal stability, reduces membrane fluidity, and, 
consequently, contributes to an increased EE [45].
Different compounds used for surface modification, in order to obtain a pro-
longed blood circulation or modified drug release, must be evaluated during risk 
identification and analysis. For example, when chitosan was used for coating, its 
concentration, solubility, and molecular weight influenced liposomal size [46]. In 
the case of polyethylene glycols (PEGs), the molecular weight and the density on 
liposomal surface influenced the biodistribution and size [47].
Besides the nature of liposomal components, their concentration and ratios 
between them are also critical. Some of these ratios, identified in risk assessments 
of different studies, are: organic phase-to-aqueous phase ratio; cholesterol-to-
lecithin ratio; chloroform-to-methanol ratio; phospholipids-to-cholesterol molar 
ratio; and drug-to-lipid ratio [40, 46, 48, 49].
Regarding the preparation process, many techniques and methods like film 
hydration, emulsification, and reverse phase evaporation were developed but the 
most used one remains the film hydration method [37]. For this method to be 
efficient from the viewpoint of EE, parameters like temperature or rotation speed 
in the evaporation and hydration steps are critical and must be optimized [41, 49]. 
Film hydration method’s great disadvantage is that the obtained liposomes are in 
the vast majority of micron size with a multilamellar structure, being characterized 
by a high percentage of lipids and a reduced internal volume. Thus, a reduction in 
particle size is mandatory, to increase their internal volume and to have a controlled 
size and narrow particle size distribution [30, 37]. For reduction of liposomal size, 
several techniques like sonication, freeze-thaw cycling, or extrusion may be used. 
Comparing these size-reduction methods through a screening experimental design, 
they were found to be critical for particle size distribution but also for EE [30]. 
When extrusion through membranes is used for size reduction, membrane pore 
size, temperature, and applied pressure are important CPPs because these factors 
define the final particle size and can seriously influence the final EE [30]. Sonication 
process also needs optimization as regards its time in order to achieve the desired 
liposomal size [46]. For the freeze-thaw cycling process, the number of the cycles 
might be taken into consideration for further optimization in order to get the desired 
particle size [30].
After the risk assessment, next step in QbD development is linking the identi-
fied CMAs and CPPs to CQAs by using Design of Experiments (DoE). The greatest 
advantage of using DoE is that it can track the interactions between the studied fac-
tors, CMAs and CPPs, and it can establish a quantitative relationship between the 
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identified variables and the results [36]. For a better understanding of this concept 
in liposomes development, the most important CQAs will be discussed further, and 
how CMAs and CPPs can influence them according to different studies.
3.1 Drug content
The drug content is most frequently optimized in terms of EE than drug concen-
tration as EE reflects better the preparation process performance and robustness. 
According to published data, the most influential factors for EE are: the amount 
of drug and phospholipids; cholesterol concentration; the nature of lipids and 
drug; the interactions between different components; the lipid-to-drug ratio; and 
several process parameters. Among these, several studies established, through 
DoE approaches, that lipid molar ratio and lipid-to-drug ratio are the most critical 
parameters for EE optimization. Using a great amount of lipids for liposome prepa-
ration favors the formation of many vesicles with a significant internal volume for 
drug encapsulation and, consequently, the EE of hydrophilic drugs increases [30, 
45]. Including cholesterol in liposome formulations increases not only their stabil-
ity but also the drug content, due to the so-called “pocket” theory, presuming that 
cholesterol can generate different size pockets inside the lipid bilayer where API can 
be entrapped [45]. The use of unsaturated lipids was shown to have a similar effect, 
the unsaturated lipids forming pockets inside the lipid bilayer where lipophilic 
drugs can be entrapped [50]. By increasing lipid-to-drug ratio from 1:1 to 10:1, 
the EE of ritonavir, a lipophilic drug, was doubled from 45 to 90% [43]. The ratio 
between phospholipid concentration and drug concentration was demonstrated to 
have a significant impact on EE in the case of simvastatin. Thus, at high simvastatin 
concentration and low concentration of phospholipids, EE decreased [51].
In the case of drugs with pH-dependent solubility like doxorubicin, the EE can 
be improved by the use of active loading method at specific pH range, the pH of 
hydrating buffer and of external buffer being critical parameters [52].
Regarding the drug concentration, several studies concluded that the total 
amount of drug used for encapsulation has a breaking point from which the EE 
cannot be further increased [41, 46].
EE may also be influenced by PPs. A fractional factorial design was used to 
establish the link between PPs like hydration temperature and the number of 
freeze-thaw cycles during preparation of liposomes loaded with FK50, an immu-
nosuppressant. An interaction between these PPs was highlighted. It was observed 
that by using an increased number of cycles, and high hydration temperature, EE 
decreased, because repetition of the freeze-thaw cycle at high temperature might 
induce leakage of FK506 from the membrane of the liposomes [39]. In another 
study, it was observed that PPs like temperature during film hydration and rotation 
speed during solvent evaporation are critical. Using high temperature, above Tm, the 
concentration of the encapsulated drug increases because at high temperature, the 
lipid bilayer is more fluid and permits the entrapment of more drug. Also, using a 
high rotation speed at the film formation can have a great impact on EE because this 
CPP leads to formation of a thinner lipid bilayer which can easily be hydrated [53].
3.2 Particle size and size distribution
Maintaining a controlled particle size and low PDI is one of the main challenges 
when preparing liposomes, and optimization of these parameters is improved 
through the use of DoE. There are many critical factors influencing these param-
eters, both formulation and process related. For example, the influence of phospho-
lipid concentration, active substances (curcumin and doxorubicin) concentration, 
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or in the lipid bilayer [40]. In order to achieve a greater therapeutic effect, more 
than one active substance may be encapsulated in the same product, so different 
physiochemical properties of one may influence the other/others drug entrapment 
process [40, 41]. Besides this, their octanol/buffer partition must also be taken into 
consideration because a low partition will lead to a prolonged release of the drug 
and vice versa [42].
Regarding the lipids, their physicochemical characteristics are also important. 
For example, lipids that contain unsaturated fatty acids are predisposed to degrada-
tion reactions like oxidation or hydrolysis and those which contain saturated fatty 
acids have a higher transition temperature (Tm) [43]. Another specific characteristic 
of lipids is their chain length. Usually, a shorter chain length will contribute to a 
thinner lipid bilayer and a larger internal volume for drug encapsulation. However, 
comparing three lipids with a difference of two carbon atoms between them, the 
lipid bilayer thickness obtained did not differ with more than 1 nm and a very small 
difference in liposomes’ size and EE was observed [30]. Lipid properties can have a 
great impact on liposomes’ membrane fluidity, permeability, or charge [44]. In this 
regard, cholesterol increases liposomal stability, reduces membrane fluidity, and, 
consequently, contributes to an increased EE [45].
Different compounds used for surface modification, in order to obtain a pro-
longed blood circulation or modified drug release, must be evaluated during risk 
identification and analysis. For example, when chitosan was used for coating, its 
concentration, solubility, and molecular weight influenced liposomal size [46]. In 
the case of polyethylene glycols (PEGs), the molecular weight and the density on 
liposomal surface influenced the biodistribution and size [47].
Besides the nature of liposomal components, their concentration and ratios 
between them are also critical. Some of these ratios, identified in risk assessments 
of different studies, are: organic phase-to-aqueous phase ratio; cholesterol-to-
lecithin ratio; chloroform-to-methanol ratio; phospholipids-to-cholesterol molar 
ratio; and drug-to-lipid ratio [40, 46, 48, 49].
Regarding the preparation process, many techniques and methods like film 
hydration, emulsification, and reverse phase evaporation were developed but the 
most used one remains the film hydration method [37]. For this method to be 
efficient from the viewpoint of EE, parameters like temperature or rotation speed 
in the evaporation and hydration steps are critical and must be optimized [41, 49]. 
Film hydration method’s great disadvantage is that the obtained liposomes are in 
the vast majority of micron size with a multilamellar structure, being characterized 
by a high percentage of lipids and a reduced internal volume. Thus, a reduction in 
particle size is mandatory, to increase their internal volume and to have a controlled 
size and narrow particle size distribution [30, 37]. For reduction of liposomal size, 
several techniques like sonication, freeze-thaw cycling, or extrusion may be used. 
Comparing these size-reduction methods through a screening experimental design, 
they were found to be critical for particle size distribution but also for EE [30]. 
When extrusion through membranes is used for size reduction, membrane pore 
size, temperature, and applied pressure are important CPPs because these factors 
define the final particle size and can seriously influence the final EE [30]. Sonication 
process also needs optimization as regards its time in order to achieve the desired 
liposomal size [46]. For the freeze-thaw cycling process, the number of the cycles 
might be taken into consideration for further optimization in order to get the desired 
particle size [30].
After the risk assessment, next step in QbD development is linking the identi-
fied CMAs and CPPs to CQAs by using Design of Experiments (DoE). The greatest 
advantage of using DoE is that it can track the interactions between the studied fac-
tors, CMAs and CPPs, and it can establish a quantitative relationship between the 
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identified variables and the results [36]. For a better understanding of this concept 
in liposomes development, the most important CQAs will be discussed further, and 
how CMAs and CPPs can influence them according to different studies.
3.1 Drug content
The drug content is most frequently optimized in terms of EE than drug concen-
tration as EE reflects better the preparation process performance and robustness. 
According to published data, the most influential factors for EE are: the amount 
of drug and phospholipids; cholesterol concentration; the nature of lipids and 
drug; the interactions between different components; the lipid-to-drug ratio; and 
several process parameters. Among these, several studies established, through 
DoE approaches, that lipid molar ratio and lipid-to-drug ratio are the most critical 
parameters for EE optimization. Using a great amount of lipids for liposome prepa-
ration favors the formation of many vesicles with a significant internal volume for 
drug encapsulation and, consequently, the EE of hydrophilic drugs increases [30, 
45]. Including cholesterol in liposome formulations increases not only their stabil-
ity but also the drug content, due to the so-called “pocket” theory, presuming that 
cholesterol can generate different size pockets inside the lipid bilayer where API can 
be entrapped [45]. The use of unsaturated lipids was shown to have a similar effect, 
the unsaturated lipids forming pockets inside the lipid bilayer where lipophilic 
drugs can be entrapped [50]. By increasing lipid-to-drug ratio from 1:1 to 10:1, 
the EE of ritonavir, a lipophilic drug, was doubled from 45 to 90% [43]. The ratio 
between phospholipid concentration and drug concentration was demonstrated to 
have a significant impact on EE in the case of simvastatin. Thus, at high simvastatin 
concentration and low concentration of phospholipids, EE decreased [51].
In the case of drugs with pH-dependent solubility like doxorubicin, the EE can 
be improved by the use of active loading method at specific pH range, the pH of 
hydrating buffer and of external buffer being critical parameters [52].
Regarding the drug concentration, several studies concluded that the total 
amount of drug used for encapsulation has a breaking point from which the EE 
cannot be further increased [41, 46].
EE may also be influenced by PPs. A fractional factorial design was used to 
establish the link between PPs like hydration temperature and the number of 
freeze-thaw cycles during preparation of liposomes loaded with FK50, an immu-
nosuppressant. An interaction between these PPs was highlighted. It was observed 
that by using an increased number of cycles, and high hydration temperature, EE 
decreased, because repetition of the freeze-thaw cycle at high temperature might 
induce leakage of FK506 from the membrane of the liposomes [39]. In another 
study, it was observed that PPs like temperature during film hydration and rotation 
speed during solvent evaporation are critical. Using high temperature, above Tm, the 
concentration of the encapsulated drug increases because at high temperature, the 
lipid bilayer is more fluid and permits the entrapment of more drug. Also, using a 
high rotation speed at the film formation can have a great impact on EE because this 
CPP leads to formation of a thinner lipid bilayer which can easily be hydrated [53].
3.2 Particle size and size distribution
Maintaining a controlled particle size and low PDI is one of the main challenges 
when preparing liposomes, and optimization of these parameters is improved 
through the use of DoE. There are many critical factors influencing these param-
eters, both formulation and process related. For example, the influence of phospho-
lipid concentration, active substances (curcumin and doxorubicin) concentration, 
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working temperature, buffer pH, and phospholipid-to-cholesterol ratio, on 
liposomal size, was examined through a screening experimental design. Out of the 
studied factors, only phospholipid concentration and phospholipid-to-cholesterol 
ratio significantly influenced the size, while the concentration of the drugs and 
the working conditions were not critical for particle size. Noteworthy, none of the 
studied parameters influenced particle size distribution [41].
Regarding the effect of lipid concentration, different studies showed contradic-
tory results on the size in relation to this factor [43, 46]. Usually, on increasing 
lipid concentration, liposomal size increases, simultaneously with PDI values [54]. 
Another observation was that increasing lipid concentration over a certain value 
leads to smaller size, probably due to lipid bilayer rearrangement into a bigger 
number of liposomes with smaller size and better size distribution [55]. Depending 
on the lipid type, a different influence on liposomal size was observed [56].
The active substances influence liposomal size depending on their physico-
chemical properties. It was observed that quercetin, a lipophilic compound, might 
replace some lipids in the lipid bilayer causing a reduction in size when it is used in 
high concentrations [55]. On the other hand, high concentrations of pravastatin, 
a hydrosoluble compound, led to a small size of liposomes due to an interaction 
between the active substance and the lipids [53].
3.3 Zeta potential
This parameter is influenced by formulation factors like ionic strength, pH, 
bilayer composition, or charged lipids and PPs like sonication time [48, 57]. In order 
to modulate the ZP values, different stabilizers, such as stearylamine and diacetyl 
phosphate, or modified lipids, such as poly(2-ethyl-2-oxazoline) (PEtOz) or PEG, 
can be incorporated in lipid bilayer. The concentration of these excipients may be 
optimized such as to obtain optimal stability [50, 57]. In conventional liposomes, 
cholesterol-to-lecithin ratio influences the zeta potential value [48]. Through DoE, 
several papers established the critical parameters influencing the zeta potential 
values. For example, a screening design study was used to determine which of 
the formulation factors (lipid concentration, cholesterol concentration, chitosan 
concentration, drug concentration, organic phase/aqueous phase ratio) and process 
parameters (temperature, stirring speed, sonication time) had a significant influ-
ence on zeta potential of chitosan-coated liposomes. As expected, chitosan con-
centration was a critical parameter, along with the temperature, which favored the 
coating process through reduction of vesicles size [46].
3.4 In vivo stability and drug release
By choosing a suitable lipid bilayer composition, a higher stability in vivo might 
be achieved. In order to sustain this, it was observed that using saturated lipids 
or cholesterol in formulations, lipid bilayer stability is increased and liposomal 
uptake by mononuclear phagocyte system will be reduced. Another used pathway 
is incorporation of different excipients, such as ganglioside GM1, phosphatidylino-
sitol or PEG-lipids, creating a steric barrier which prevents their clearance from the 
system [42]. The organs in which liposomes accumulate for being eliminated are 
lungs, liver, spleen, and kidneys. It was observed that those liposomes with negative 
surface charge present a higher uptake in tumor cells and a slower uptake in liver 
cells [58]. In a study, four liposome formulations were compared regarding their 
in vivo stability, by tracking their accumulation in spleen. Results showed that the 
molecular weight of PEG attached to their surface as well as particle size were CMAs 
influencing the accumulation in the spleen [47].
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Depending on the lipophilic or hydrophilic character of the active substance, the 
kinetics of release is different because the diffusion through liposomal membrane 
is influenced by its physiochemical properties [41]. This behavior was shown when 
the release of two different lipophilic drugs and a hydrophilic drug from the same 
liposomal system was studied in vitro. The lipophilic agent displayed prolonged 
release and a smaller total drug release in comparison with the hydrophilic one due 
to their different characteristics [40].
For pH-sensitive liposomes, the objective in terms of in vitro drug release is to 
have a very good stability of the encapsulated drug under physiological conditions 
and triggered drug release at certain pH values. To achieve this, the use of excipi-
ents having a membrane-destabilizing effect and their concentration are critical 
parameters [52, 56].
4. Defining the product and process design space
The design space (DS) is a multidimensional combination and interaction of 
the input variables, such as material attributes, and process parameters that have 
been shown to assure quality [9]. Thus, the advantage of DS determination is that it 
establishes the operating region which ensures consistent product qualities between 
different batches. Working within the DS, the product will meet the specifications 
mentioned in the QTPP, while moving out of it is considered a change that would 
normally require a regulatory approval in the case of authorized products [9].
Determination of the DS is based on multivariate analysis, considering the main 
effects of factors as well as their interaction, which helps in determining an opera-
tional region based on a predefined confidence level. The DS includes the product 
design space and process design space. The product DS is established with product’s 
CQAs as dimensions, while the process design space is exhibited as CQAs with 
respect to CPPs [59].
One approach to establish the DS for liposomal products is to take simultane-
ously into consideration both formulation factors and CPPs. This method was 
used for the determination of the DS for lyophilized liposomes with simvastatin. 
Thus, the cholesterol concentration, the PEG proportion, the cryoprotectant-to-
phospholipids molar ratio, and the number of extrusions through polycarbonate 
membranes were selected as the most influential factors for lyophilized liposome 
CQAs. Their variation range was determined, in which the established quality 
requirements of the product are met: reduced particle size, maximized drug reten-
tion during lyophilization, reduced change in phospholipid transition temperature, 
low residual moisture content. The validity of the DS was confirmed by determin-
ing the CQAs of a formulation corresponding to the robust set point, that is, the 
formulation for which the prediction errors are lowest. Thus, defining the DS was 
found to be a useful strategy for the development of stable lyophilized liposomes 
having predictable quality [60]. The same approach was used to generate the DS for 
preparation of prednisolon-loaded long-circulating liposomes at laboratory scale. 
In this case, the selected formulation parameters were prednisolon concentration 
and the PEG proportion in lipidic membrane, and the process parameters were the 
extrusion temperature and the rotation speed at the hydration of the lipid film. The 
DS was developed such as to ensure high liposomal drug concentration, high EE, 
and controlled size [49].
When process parameters are not found as critical for the quality of the product, 
or their impact on quality is easily controlled by fixing a certain operating level, the 
DS is proposed as a function of formulation variables. This approach has been used 
in several studies, the most studied formulation variables being the active substance 
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working temperature, buffer pH, and phospholipid-to-cholesterol ratio, on 
liposomal size, was examined through a screening experimental design. Out of the 
studied factors, only phospholipid concentration and phospholipid-to-cholesterol 
ratio significantly influenced the size, while the concentration of the drugs and 
the working conditions were not critical for particle size. Noteworthy, none of the 
studied parameters influenced particle size distribution [41].
Regarding the effect of lipid concentration, different studies showed contradic-
tory results on the size in relation to this factor [43, 46]. Usually, on increasing 
lipid concentration, liposomal size increases, simultaneously with PDI values [54]. 
Another observation was that increasing lipid concentration over a certain value 
leads to smaller size, probably due to lipid bilayer rearrangement into a bigger 
number of liposomes with smaller size and better size distribution [55]. Depending 
on the lipid type, a different influence on liposomal size was observed [56].
The active substances influence liposomal size depending on their physico-
chemical properties. It was observed that quercetin, a lipophilic compound, might 
replace some lipids in the lipid bilayer causing a reduction in size when it is used in 
high concentrations [55]. On the other hand, high concentrations of pravastatin, 
a hydrosoluble compound, led to a small size of liposomes due to an interaction 
between the active substance and the lipids [53].
3.3 Zeta potential
This parameter is influenced by formulation factors like ionic strength, pH, 
bilayer composition, or charged lipids and PPs like sonication time [48, 57]. In order 
to modulate the ZP values, different stabilizers, such as stearylamine and diacetyl 
phosphate, or modified lipids, such as poly(2-ethyl-2-oxazoline) (PEtOz) or PEG, 
can be incorporated in lipid bilayer. The concentration of these excipients may be 
optimized such as to obtain optimal stability [50, 57]. In conventional liposomes, 
cholesterol-to-lecithin ratio influences the zeta potential value [48]. Through DoE, 
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Depending on the lipophilic or hydrophilic character of the active substance, the 
kinetics of release is different because the diffusion through liposomal membrane 
is influenced by its physiochemical properties [41]. This behavior was shown when 
the release of two different lipophilic drugs and a hydrophilic drug from the same 
liposomal system was studied in vitro. The lipophilic agent displayed prolonged 
release and a smaller total drug release in comparison with the hydrophilic one due 
to their different characteristics [40].
For pH-sensitive liposomes, the objective in terms of in vitro drug release is to 
have a very good stability of the encapsulated drug under physiological conditions 
and triggered drug release at certain pH values. To achieve this, the use of excipi-
ents having a membrane-destabilizing effect and their concentration are critical 
parameters [52, 56].
4. Defining the product and process design space
The design space (DS) is a multidimensional combination and interaction of 
the input variables, such as material attributes, and process parameters that have 
been shown to assure quality [9]. Thus, the advantage of DS determination is that it 
establishes the operating region which ensures consistent product qualities between 
different batches. Working within the DS, the product will meet the specifications 
mentioned in the QTPP, while moving out of it is considered a change that would 
normally require a regulatory approval in the case of authorized products [9].
Determination of the DS is based on multivariate analysis, considering the main 
effects of factors as well as their interaction, which helps in determining an opera-
tional region based on a predefined confidence level. The DS includes the product 
design space and process design space. The product DS is established with product’s 
CQAs as dimensions, while the process design space is exhibited as CQAs with 
respect to CPPs [59].
One approach to establish the DS for liposomal products is to take simultane-
ously into consideration both formulation factors and CPPs. This method was 
used for the determination of the DS for lyophilized liposomes with simvastatin. 
Thus, the cholesterol concentration, the PEG proportion, the cryoprotectant-to-
phospholipids molar ratio, and the number of extrusions through polycarbonate 
membranes were selected as the most influential factors for lyophilized liposome 
CQAs. Their variation range was determined, in which the established quality 
requirements of the product are met: reduced particle size, maximized drug reten-
tion during lyophilization, reduced change in phospholipid transition temperature, 
low residual moisture content. The validity of the DS was confirmed by determin-
ing the CQAs of a formulation corresponding to the robust set point, that is, the 
formulation for which the prediction errors are lowest. Thus, defining the DS was 
found to be a useful strategy for the development of stable lyophilized liposomes 
having predictable quality [60]. The same approach was used to generate the DS for 
preparation of prednisolon-loaded long-circulating liposomes at laboratory scale. 
In this case, the selected formulation parameters were prednisolon concentration 
and the PEG proportion in lipidic membrane, and the process parameters were the 
extrusion temperature and the rotation speed at the hydration of the lipid film. The 
DS was developed such as to ensure high liposomal drug concentration, high EE, 
and controlled size [49].
When process parameters are not found as critical for the quality of the product, 
or their impact on quality is easily controlled by fixing a certain operating level, the 
DS is proposed as a function of formulation variables. This approach has been used 
in several studies, the most studied formulation variables being the active substance 
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concentration and the composition of the lipid membrane. For example, the DS for 
liposomes with tenofovir was constructed with respect to phospholipid, concentra-
tion, cholesterol concentration, and drug concentration, with a focus to obtain high 
drug encapsulation efficiency, as this was considered the most difficult property 
to predict and control for liposomes containing hydrophilic drugs. Other quality 
attributes considered critical in the study, particle size and stability, were controlled 
by the pore size of the extrusion membrane and by storing the samples at low tem-
perature, respectively [61]. In another paper, the DS for chitosan-coated liposomes 
was established as a function of drug concentration, chitosan concentration, and 
the organic phase-to-aqueous phase ratio during liposome preparation by ethanol 
injection technique. These variables were found to be the only significant factors 
affecting the CQAs of the product, although other formulation and process param-
eters were evaluated through a screening study. The composite desirability function 
based on constraints was used to determine the conditions that would result in an 
optimal formulation design, in terms of particle size, encapsulation efficiency, and 
coating efficiency. Target values were selected for the mentioned quality attributes, 
and, on the basis of these target values, the optimum values for each variable or 
processing parameter were obtained. In an additional step, the robustness of the DS 
was analyzed and the results showed that the selected CPPs may help minimize the 
variations in QAs that might arise due to the variability of the raw materials [46].
The development of liposomal systems entrapping more than one active sub-
stances is more complex, because the properties of each will influence the CQAs of 
the product and their stability in the processing conditions will impact the process 
parameters. In this regard, a group of authors established and evaluated the DS for 
long-circulating liposomes co-encapsulated with curcumin and doxorubicin. DS 
development was based on a previous screening study, which revealed the critical 
parameters, that is, phospholipid concentration, the phospholipid-to-cholesterol 
molar ratio, doxorubicin concentration, and curcumin concentration. The purpose 
was to obtain the variation range of these factors for which the size of the liposomes 
is minimized and the encapsulation efficiencies of both drugs are maximized. The 
DS was established as the region within which the prediction of the CQAs is made 
with a probability of failure of less than 1%. Moreover, a DS hypercube was set out 
as a restricted zone in the DS where factors’ values can vary independent of each 
other, without influencing the quality of the product [41].
The incomplete understanding of the manufacturing process is a major bar-
rier in liposomal products’ industrial production and clinical application. The 
destabilization of their structure during long-time storage as aqueous dispersions 
revealed the need for complex fabrication processes, involving drying steps such as 
lyophilization and spray drying. The key to the successful design and preparation of 
optimal liposomal dry powder formulations is an understanding of the significance 
of the drying process parameters [62]. This aim was achieved by several authors by 
determining the DS for lyophilization or spray drying process.
The DS for the freeze-drying process of pravastatin-loaded long-circulating 
liposomes was established as a function of the freezing rate and shelf temperature 
during primary drying. The two process parameters were found to have a great 
impact on product’s CQAs, along with the presence of an annealing step. The condi-
tions to obtain freeze-dried liposomes with the desired characteristics were gener-
ated using the combination trehalose-mannitol as cryoprotectant and by including 
an annealing step. A series of limitations and target values were applied for the criti-
cal quality attributes of the lyophilized product. Thus, the DS was constructed such 
as to ensure high drug retention after lyophilization, particle size below a certain 
value, low zeta potential, low residual moisture content, and a short duration of the 
primary drying. Out of the DS, an optimal formulation was selected and testing this 
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formulation confirmed that the process delivers the desired quality of the product, 
as long as it is operated within the DS [63].
A process design space for spray drying of liposomes was developed such as to 
get a product that met the criteria for all CQAs of an inhalable powder formulation. 
When developing an inhalable product, the mass median aerodynamic diameter 
(MMAD) is the most important CQA, as this characteristic influences the deposi-
tion in the conducting airway. Besides this, the size stabilization, relative moisture 
content, and process yield were identified as CQAs. The DS was plotted by impos-
ing restrictions especially for MMAD, which should be within the range 4.5–5.5 μm, 
but also for liposome size ratio (before/after drying) and the yield of the process, 
while for moisture content, no restrictions were set, as acceptably low values were 
obtained for all the experiments. First, an optimal operating space (OOS) was 
identified with a high feed flow rate, a low outlet temperature, a medium aspirator 
rate and in the area of low feedstock concentration and high atomizing airflow. The 
MMAD was the QA restricting the entire ODS to the low feedstock concentration 
and high atomizing airflow, whereas the other CQAs met the imposed criteria in a 
larger space [64].
5. The control strategy
Due to the great success of liposomal systems, not only in pharmaceutical 
formulation but also in cosmetics and food industry, there is a huge demand on 
developing and standardizing analytical and bioanalytical methods for liposome 
complete characterization, as well as for their detection in blood and tissues. 
Official guidance regarding the manufacturing and controls recommend several 
methods for lipid components as well as for the drug products [65]. According to 
FDA guideline, “liposome structures and integrity are important physicochemical 
properties and they reflect the ability of the liposome drug formulation to contain 
the drug substance and to retain the drug substance within the appropriate lipo-
some structure” [65].
A key issue in the control of liposomes is closely related with the quality control 
of the lipid components, including modified lipids, which could dramatically influ-
ence the properties and performances of liposome drug product [65]. The quality 
of the final product is influenced by the source of lipids and also by the type of the 
lipids: synthetic, semi-synthetic, or natural.
All types of separation methods, such as gas chromatography (GC) or liquid 
chromatography (LC), capillary electrophoresis (CE), gel electrophoresis, or 
electrochromatography have proved their value in the analysis of lipid components 
of liposomes [66–68]. In order to evaluate the chemical stability of the liposomes, 
it is mandatory to assess the chemical stability of the lipid components in the final 
drug formulation, taking into account that some lipids could be degraded by oxida-
tion or hydrolysis. From the practical point of view, most of the separation methods 
offer important information on this matter. The broad versatility, high selectivity, 
efficiency, and low time of analysis are making them a good choice.
While the analysis of lipids using liquid chromatography does not need a long 
stage of pretreatment, the lipids analyzed using gas chromatography have to be 
derivatized in order to obtain more volatile compounds which are not turning into 
degradation products at their boiling point [69]. For fatty acids, the most used 
derivatization method consists in the esterification of the acids and their transfor-
mation in methyl esters. The esterification takes place under various conditions of 
temperature, mixing process, using different catalysts and for various periods of 
time. There are plenty of studies among scientific literature about derivatization 
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parameters, that is, phospholipid concentration, the phospholipid-to-cholesterol 
molar ratio, doxorubicin concentration, and curcumin concentration. The purpose 
was to obtain the variation range of these factors for which the size of the liposomes 
is minimized and the encapsulation efficiencies of both drugs are maximized. The 
DS was established as the region within which the prediction of the CQAs is made 
with a probability of failure of less than 1%. Moreover, a DS hypercube was set out 
as a restricted zone in the DS where factors’ values can vary independent of each 
other, without influencing the quality of the product [41].
The incomplete understanding of the manufacturing process is a major bar-
rier in liposomal products’ industrial production and clinical application. The 
destabilization of their structure during long-time storage as aqueous dispersions 
revealed the need for complex fabrication processes, involving drying steps such as 
lyophilization and spray drying. The key to the successful design and preparation of 
optimal liposomal dry powder formulations is an understanding of the significance 
of the drying process parameters [62]. This aim was achieved by several authors by 
determining the DS for lyophilization or spray drying process.
The DS for the freeze-drying process of pravastatin-loaded long-circulating 
liposomes was established as a function of the freezing rate and shelf temperature 
during primary drying. The two process parameters were found to have a great 
impact on product’s CQAs, along with the presence of an annealing step. The condi-
tions to obtain freeze-dried liposomes with the desired characteristics were gener-
ated using the combination trehalose-mannitol as cryoprotectant and by including 
an annealing step. A series of limitations and target values were applied for the criti-
cal quality attributes of the lyophilized product. Thus, the DS was constructed such 
as to ensure high drug retention after lyophilization, particle size below a certain 
value, low zeta potential, low residual moisture content, and a short duration of the 
primary drying. Out of the DS, an optimal formulation was selected and testing this 
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formulation confirmed that the process delivers the desired quality of the product, 
as long as it is operated within the DS [63].
A process design space for spray drying of liposomes was developed such as to 
get a product that met the criteria for all CQAs of an inhalable powder formulation. 
When developing an inhalable product, the mass median aerodynamic diameter 
(MMAD) is the most important CQA, as this characteristic influences the deposi-
tion in the conducting airway. Besides this, the size stabilization, relative moisture 
content, and process yield were identified as CQAs. The DS was plotted by impos-
ing restrictions especially for MMAD, which should be within the range 4.5–5.5 μm, 
but also for liposome size ratio (before/after drying) and the yield of the process, 
while for moisture content, no restrictions were set, as acceptably low values were 
obtained for all the experiments. First, an optimal operating space (OOS) was 
identified with a high feed flow rate, a low outlet temperature, a medium aspirator 
rate and in the area of low feedstock concentration and high atomizing airflow. The 
MMAD was the QA restricting the entire ODS to the low feedstock concentration 
and high atomizing airflow, whereas the other CQAs met the imposed criteria in a 
larger space [64].
5. The control strategy
Due to the great success of liposomal systems, not only in pharmaceutical 
formulation but also in cosmetics and food industry, there is a huge demand on 
developing and standardizing analytical and bioanalytical methods for liposome 
complete characterization, as well as for their detection in blood and tissues. 
Official guidance regarding the manufacturing and controls recommend several 
methods for lipid components as well as for the drug products [65]. According to 
FDA guideline, “liposome structures and integrity are important physicochemical 
properties and they reflect the ability of the liposome drug formulation to contain 
the drug substance and to retain the drug substance within the appropriate lipo-
some structure” [65].
A key issue in the control of liposomes is closely related with the quality control 
of the lipid components, including modified lipids, which could dramatically influ-
ence the properties and performances of liposome drug product [65]. The quality 
of the final product is influenced by the source of lipids and also by the type of the 
lipids: synthetic, semi-synthetic, or natural.
All types of separation methods, such as gas chromatography (GC) or liquid 
chromatography (LC), capillary electrophoresis (CE), gel electrophoresis, or 
electrochromatography have proved their value in the analysis of lipid components 
of liposomes [66–68]. In order to evaluate the chemical stability of the liposomes, 
it is mandatory to assess the chemical stability of the lipid components in the final 
drug formulation, taking into account that some lipids could be degraded by oxida-
tion or hydrolysis. From the practical point of view, most of the separation methods 
offer important information on this matter. The broad versatility, high selectivity, 
efficiency, and low time of analysis are making them a good choice.
While the analysis of lipids using liquid chromatography does not need a long 
stage of pretreatment, the lipids analyzed using gas chromatography have to be 
derivatized in order to obtain more volatile compounds which are not turning into 
degradation products at their boiling point [69]. For fatty acids, the most used 
derivatization method consists in the esterification of the acids and their transfor-
mation in methyl esters. The esterification takes place under various conditions of 
temperature, mixing process, using different catalysts and for various periods of 
time. There are plenty of studies among scientific literature about derivatization 
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methods of fatty acids for their GC analysis, researchers being still interested in 
improving the pretreatment of these compounds to obtain an efficient and rapid 
process [70].
Even though the literature abounds in examples of separation techniques applied 
for lipid detection and quantification, some drawbacks are obvious: poor solubil-
ity, poor absorbance properties, the need for derivatization, and laborious sample 
preparations. Nevertheless, the hyphenation between techniques could overcome 
the drawbacks and offers promising results.
Regarding the control of the final product, the following properties are gener-
ally determined to characterize a liposome drug formulation: morphology; surface 
charge (expressed as zeta potential); particle size (average diameter) and polydis-
persity index; encapsulation efficiency; the amount of drug relative to the amount 
of lipids; phase transition; residual solvents; in vitro and in vivo drug release [71]. 
Variability in these properties may lead to changes in the quality of the liposomal 
drug products, including leakage of the drug from the liposomes. The QAs moni-
tored for liposomes are presented in Table 2, together with the currently employed 
methods of analysis.
Particle size is one of the crucial parameters for further in vivo application of 
liposomes. The required size is usually in the range 20–250 nm. When using micros-
copy techniques, one will obtain a high-resolution three-dimensional profile of the 
vesicle surface under study. For instance, AFM permits liposomes’ visualization 
without alteration of their native form, given that the requisite surface immobiliza-
tion does not adversely affect the sample and that the force of the probe itself does 
not have deleterious effects on the vesicles [75]. AFM is a rapid, powerful, and 
relatively non invasive technique and compared to TEM, does not requiers compli-
cated sample preparation and removal of liposomes from their native environment. 
Additionally, TEM provides information on the size distribution and shape of 
vesicles. Unfortunately, liposomes can suffer from structure perturbations triggered 
by the high vacuum conditions and the staining process.




Angle X-ray scattering (SAXS)
Freeze fracture technique with subsequent transmission 
electron microscopy
[71–73]
Net charge (zeta potential) ELS [74]
Particle size Microscopy techniques (TEM, AFM, SEM)
SEC
Field-flow fractionation and static
DLS
[74, 75]
Drug encapsulation efficiency Spectroscopy
LC
[75]
In vitro drug release Spectroscopy
LC
[75]
In vivo drug release Radiolabeling, fluorescence labeling, MRI, CT, MS [75]
AFM, atomic force microscopy; TEM, transmission electron microscopy; SEM, scanning electron microscopy; ELS, 
electrophoretic light scattering; LC, liquid chromatography; SEC, size-exclusion chromatography; DLS, dynamic 
light scattering; MRI, magnetic resonance imaging; CT, computed tomography; MS, mass spectrometry.
Table 2. 
The quality attributes monitored for liposomal products.
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To measure particle size and size distribution, three types of techniques 
could be used: all together, separation, and particle-by-particle counting. In the 
first case, multi-angle (static) and dynamic light scattering (MALS and DLS, 
respectively) techniques permit the calculation of the average particle size and 
charge from the signal generated by multiple particles within the sample. Even 
though these techniques are fast, they have low resolution and do not provide 
the particle concentration. Separation techniques, such as disk centrifuge and 
field-flow fractionation, have the advantage of improving size analysis resolution 
by using differences in the sample properties, typically sedimentation rates, to 
pre-separate the sample prior to light-based (absorbance or scattering) analysis. 
The separation techniques do not measure particle concentration or charge, and 
they often suffer from separation-based issues. More effective are particle-by-
particle counting techniques, such as tunable resistive pulse sensors (TRPSs). 
The main advantage is the possibility to measure the properties of individual 
liposomes, offering a direct measurement of the particle concentration as well as 
high resolution and more accurate analysis of the particle size and charge (zeta 
potential) distribution. This ability to simultaneously measure the distribution of 
both the size and zeta potential represents a new and effective means of analyzing 
liposome properties [76].
To measure the zeta potential, ELS technique is currently used. It consist in 
using heterodyne scattering methods in which a fraction of the laser beam is split 
away by a mirror before reaching the sample, and is directed to the detector where it 
is combined with scattered light from particles diffusing in the sample. The frac-
tion of redirected light is referred to as the “local oscillator” and, unlike the light 
scattered by the sample, does not fluctuate. It is used as a reference beam and must 
be much larger than the average intensity of the scattered light produced by the dif-
fusing particles. To determine the zeta potential, the electrophoretic mobility must 
first be ascertained [77].
The surface modification of liposomes is sometimes performed in order to 
increase their in vivo drug-delivery performances. As mentioned earlier, several 
ways of modifying the surfaces were reported, like the addition of polyethylene 
glycol (PEG) chains, or the attachment of antibodies and cellular receptor recogni-
tion molecules (e.g., the RGD peptide) as molecular targeting probes. Tracking the 
successful modification of liposomes is made by measuring the change in their elec-
trophoretic mobility, in fact the modification of their zeta potential arising from the 
change in the number of charged surface groups. Another method for measuring 
the zeta potential of liposome particles is via ensemble light scattering techniques, 
which use a similar principle as DLS [78].
Within the control strategy, process analytical technology (PAT) has been evi-
denced lately as a significant tool for measuring parameters and attributes related 
to the active substance, the finished product as well as the processing conditions. 
Among the PAT tools, in the field of liposomes, near-infrared spectroscopy (NIRs) 
has been shown to be useful for the chemical characterization of liposomes in terms 
of the composition of the lipid membrane, as well as for the simultaneous quantifi-
cation of excipients and active substance [79, 80].
Besides the large-scale production, which is a major challenge, the standardiza-
tion of analysis procedures easily scalable is another important goal in practical 
application of liposomes. The liposome production is done in small size batches 
compared with other pharmaceutical products which are produced in large batches 
[71]. However, the possible application of liposomes and the increasing number of 
clinical trials involving liposomes prove the fact that this field of research is very 
dynamic and the synthesis and analysis methods become more effective, encourag-
ing their application in the development of new drug carriers.
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not have deleterious effects on the vesicles [75]. AFM is a rapid, powerful, and 
relatively non invasive technique and compared to TEM, does not requiers compli-
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scattered by the sample, does not fluctuate. It is used as a reference beam and must 
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application of liposomes. The liposome production is done in small size batches 
compared with other pharmaceutical products which are produced in large batches 
[71]. However, the possible application of liposomes and the increasing number of 
clinical trials involving liposomes prove the fact that this field of research is very 
dynamic and the synthesis and analysis methods become more effective, encourag-
ing their application in the development of new drug carriers.
Liposomes - Advances and Perspectives
84
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
6. Conclusions
The implementation of the QbD approach in the pharmaceutical industry is 
intended to enhance the quality of pharmaceutical products through identifying, 
analyzing, and controlling all factors that could alter their quality, and, conse-
quently, its efficacy and safety. Currently, an increasing number of papers describe 
the development of liposomal products based on this risk-based approach, although 
only few are following all the steps recommended by the regulatory guidelines. 
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Liposomes have received increased attention in recent years. Nevertheless, liposomes, 
due to their various forms and applications, require further investigation. These 
structures can deliver both hydrophilic and hydrophobic drugs. The preparation of 
liposomes results in different properties for these systems. In addition, there are many 
factors and difficulties that affect the development of liposome drug delivery structures. 
The purpose of this book is to concentrate on recent developments in liposomes. The 
articles collected in this book are contributions by invited researchers with long-
standing experience in different research areas. We hope that the material presented 
here is understandable to a broad audience, not only scientists but also people with a 
general background in many different biological sciences. This volume offers up-to-date, 
expert reviews of the fast-moving field of liposomes and is divided in two major sections: 
1. Introduction; 2. Liposomes general properties
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